<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ARSB - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>ARSB</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/P15848" target="_blank" class="term-link">
                        P15848
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "ARSB";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="P15848" data-a="DESCRIPTION: Arylsulfatase B (ARSB) is a lysosomal enzyme that ..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>Arylsulfatase B (ARSB) is a lysosomal enzyme that catalyzes the hydrolysis of 4-sulfate groups from N-acetylgalactosamine residues within chondroitin-4-sulfate and dermatan sulfate. This sulfatase activity is essential for the ordered degradation of glycosaminoglycans in lysosomes. Deficiency of ARSB leads to mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome), characterized by accumulation of dermatan sulfate and chondroitin sulfate. Beyond its lysosomal role, ARSB regulates extracellular matrix composition, cell migration, and signaling pathways by controlling sulfation patterns of glycosaminoglycans.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008484" target="_blank" class="term-link">
                                    GO:0008484
                                </a>
                            </span>
                            <span class="term-label">sulfuric ester hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0008484" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This IBA annotation correctly identifies ARSB as a sulfuric ester hydrolase, which is accurate as ARSB catalyzes hydrolysis of sulfate ester bonds. This is the broader enzymatic class encompassing the more specific N-acetylgalactosamine-4-sulfatase activity. The phylogenetic evidence supporting this annotation is strong across mammalian orthologs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an appropriate molecular function term that accurately reflects the core catalytic activity of ARSB. While more general than the specific N-acetylgalactosamine-4-sulfatase activity, it correctly places ARSB in the sulfatase family. The IBA evidence based on phylogenetic conservation is robust.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity suggesting that they arose from a common ancestral gene and are members of an arylsulfatase gene family.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">See deep research file for comprehensive analysis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003943" target="_blank" class="term-link">
                                    GO:0003943
                                </a>
                            </span>
                            <span class="term-label">N-acetylgalactosamine-4-sulfatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000003
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0003943" data-r="GO_REF:0000003" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation correctly identifies the specific enzymatic activity of ARSB. The EC mapping (EC:3.1.6.12) accurately reflects that ARSB catalyzes the hydrolysis of 4-sulfate groups from N-acetylgalactosamine residues in both chondroitin sulfate and dermatan sulfate. This is the primary and most specific molecular function of ARSB.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the most precise molecular function term for ARSB and should be retained as a core annotation. Although this is IEA based on EC mapping, it is also supported by multiple experimental studies (IDA annotations from PMID:18285341 and PMID:19306108).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                                        PMID:18285341
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                                        PMID:19306108
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1793207
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004065" target="_blank" class="term-link">
                                    GO:0004065
                                </a>
                            </span>
                            <span class="term-label">arylsulfatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0004065" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation identifies ARSB as having arylsulfatase activity, which is a broader classification than the specific N-acetylgalactosamine-4-sulfatase activity. While technically correct, this term is somewhat less informative than GO:0003943.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is correct and reflects the arylsulfatase family membership of ARSB. Although broader than the specific sulfatase activity, it is appropriate to retain this alongside the more specific term, as it reflects the historical nomenclature and biochemical classification. This is also supported by a TAS annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. [...] members of an arylsulfatase gene family.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">RecName: Full=Arylsulfatase B</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005764" target="_blank" class="term-link">
                                    GO:0005764
                                </a>
                            </span>
                            <span class="term-label">lysosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0005764" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation correctly places ARSB in the lysosome, which is the primary and well-established cellular compartment where ARSB functions. ARSB is a classical lysosomal enzyme that degrades glycosaminoglycans in this organelle.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core cellular component annotation for ARSB. The lysosomal localization is extensively documented and is the primary site of ARSB function in glycosaminoglycan degradation. This is supported by both IEA and TAS evidence, as well as the original biochemical characterization of the enzyme.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Lysosome</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">Primary: ARSB is predominantly a lysosomal enzyme</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008484" target="_blank" class="term-link">
                                    GO:0008484
                                </a>
                            </span>
                            <span class="term-label">sulfuric ester hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0008484" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a duplicate annotation of the IBA sulfuric ester hydrolase activity annotation (line 2 of GOA file), but with different evidence (IEA from combined automated methods) and ortholog mapping to rat ARSB.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this is a duplicate GO term, it represents independent evidence from automated orthology mapping, which reinforces the IBA annotation. It is acceptable to have the same term with different evidence codes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009986" target="_blank" class="term-link">
                                    GO:0009986
                                </a>
                            </span>
                            <span class="term-label">cell surface</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0009986" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation indicates ARSB localizes to the cell surface. While ARSB is primarily lysosomal, there is evidence from UniProt and literature that ARSB can be detected at the cell membrane in certain cell types, particularly in colonic and prostatic epithelial cells. This extra-lysosomal localization may have functional significance.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Although ARSB is predominantly a lysosomal enzyme, the evidence for cell surface localization should not be dismissed. The deep research document notes that ARSB has been detected at cell membranes, and this may represent a non-core but biologically relevant localization. There is also an ISS annotation supporting this.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells. Membrane localization is reduced in malignant tissues.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Lysosome. Cell surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016787" target="_blank" class="term-link">
                                    GO:0016787
                                </a>
                            </span>
                            <span class="term-label">hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0016787" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a very broad molecular function term indicating that ARSB is a hydrolase, which is technically correct but not informative. This term is the parent of more specific terms like sulfuric ester hydrolase activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this term is extremely broad and not very informative, it is technically correct and represents the top-level enzymatic classification. It is acceptable to keep this alongside more specific terms, as it may be useful for broad queries. However, this is clearly less informative than the more specific sulfatase activity terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">EC=3.1.6.12 [hydrolase class]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046872" target="_blank" class="term-link">
                                    GO:0046872
                                </a>
                            </span>
                            <span class="term-label">metal ion binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0046872" data-r="GO_REF:0000043" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation indicates metal ion binding activity. ARSB requires calcium as a cofactor, binding one Ca2+ ion per subunit. The term is somewhat generic but is biochemically accurate.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ARSB does bind metal ions, specifically calcium, the current term is too generic. A more specific term would be calcium ion binding (GO:0005509), which accurately reflects the specific metal requirement documented in UniProt and Reactome. The current term should be replaced with the more specific calcium ion binding term.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005509" target="_blank" class="term-link">
                                    calcium ion binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1793207
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006914" target="_blank" class="term-link">
                                    GO:0006914
                                </a>
                            </span>
                            <span class="term-label">autophagy</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0006914" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in autophagy, based on orthology to rat ARSB. While ARSB is a lysosomal enzyme and lysosomes are involved in autophagy, there is no direct evidence that ARSB specifically participates in autophagic processes beyond being a general lysosomal enzyme.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation appears to be an over-annotation. While ARSB is lysosomal and lysosomes participate in autophagy, there is no specific evidence that ARSB has a direct functional role in autophagy itself. ARSB&#39;s primary function is glycosaminoglycan degradation, not autophagy regulation. This annotation likely arises from guilt-by-association with the lysosome rather than a specific biological role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">ARSB encodes the enzyme N-acetylgalactosamine-4-sulfatase, which hydrolyzes (removes) 4-sulfate groups from the GAGs dermatan sulfate and chondroitin-4-sulfate [does not mention autophagy as a specific function]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007584" target="_blank" class="term-link">
                                    GO:0007584
                                </a>
                            </span>
                            <span class="term-label">response to nutrient</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0007584" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in response to nutrient, based on orthology to rat. There is no specific evidence that ARSB responds to or regulates nutrient sensing beyond its general role as a lysosomal enzyme.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This appears to be an over-annotation without specific supporting evidence. While lysosomal function can be influenced by nutrient status, there is no indication that ARSB specifically mediates nutrient response pathways. This annotation likely reflects general lysosomal biology rather than a specific ARSB function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009268" target="_blank" class="term-link">
                                    GO:0009268
                                </a>
                            </span>
                            <span class="term-label">response to pH</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0009268" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation indicates ARSB is involved in response to pH. As a lysosomal enzyme, ARSB functions optimally at acidic pH (the lysosomal environment), but there is no evidence it specifically responds to or regulates pH.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an over-annotation. While ARSB activity is pH-dependent (like most lysosomal enzymes that function optimally at acidic pH), this does not mean ARSB is involved in pH response as a biological process. The term implies ARSB actively participates in sensing or responding to pH changes, which is not supported by evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010976" target="_blank" class="term-link">
                                    GO:0010976
                                </a>
                            </span>
                            <span class="term-label">positive regulation of neuron projection development</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0010976" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB positively regulates neuron projection development, based on orthology to rat. UniProt states that in the central nervous system, ARSB is a regulator of neurite outgrowth and neuronal plasticity through control of sulfate glycosaminoglycans and neurocan levels, though this is based on similarity evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While there is supporting evidence from UniProt (based on similarity) that ARSB regulates neurite outgrowth in the CNS, this appears to be a non-core, tissue-specific function rather than a primary function of ARSB. The core function is glycosaminoglycan degradation; the neuronal effects are downstream consequences of this activity in neural tissue. This should be retained but marked as non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">Neuronal development: In the central nervous system, ARSB regulates neurite outgrowth and neuronal plasticity by controlling sulfate GAG and neurocan levels</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043627" target="_blank" class="term-link">
                                    GO:0043627
                                </a>
                            </span>
                            <span class="term-label">response to estrogen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0043627" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in response to estrogen, based on orthology to rat. There is no specific evidence in the literature or UniProt that ARSB directly responds to or mediates estrogen signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This appears to be an over-annotation without supporting evidence. While ARSB expression levels might be influenced by various factors including hormones, there is no specific evidence that ARSB plays a role in estrogen response pathways. This annotation should be removed unless specific evidence emerges.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051597" target="_blank" class="term-link">
                                    GO:0051597
                                </a>
                            </span>
                            <span class="term-label">response to methylmercury</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0051597" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in response to methylmercury, based on orthology to rat. This appears to be an artifact of expression studies in rats and does not reflect a specific biological function of ARSB.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an over-annotation that likely reflects experimental conditions in rat studies rather than a genuine biological function. There is no evidence that ARSB has a specific role in methylmercury response or detoxification. This should be removed.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003943" target="_blank" class="term-link">
                                    GO:0003943
                                </a>
                            </span>
                            <span class="term-label">N-acetylgalactosamine-4-sulfatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18285341
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Distinct effects of N-acetylgalactosamine-4-sulfatase and ga...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0003943" data-r="PMID:18285341" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is experimental (IDA) confirmation of the specific N-acetylgalactosamine-4-sulfatase activity of ARSB. The study directly demonstrated that ARSB hydrolyzes sulfate groups from chondroitin sulfates and that modifying ARSB expression affects chondroitin-4-sulfate levels.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a gold-standard experimental annotation that directly demonstrates the primary molecular function of ARSB. This is core evidence supporting the specific enzymatic activity and should definitely be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                                        PMID:18285341
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS. [...] Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030207" target="_blank" class="term-link">
                                    GO:0030207
                                </a>
                            </span>
                            <span class="term-label">chondroitin sulfate proteoglycan catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18285341
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Distinct effects of N-acetylgalactosamine-4-sulfatase and ga...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0030207" data-r="PMID:18285341" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This experimental annotation indicates ARSB is involved in chondroitin sulfate proteoglycan catabolism. The study demonstrated that ARSB expression affects the content of chondroitin sulfate and its proteoglycans, with overexpression leading to reduced CS and increased syndecan-1 and decorin core protein expression.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is well-supported by experimental evidence. The study shows that ARSB affects both the glycosaminoglycan chains and the proteoglycan content, justifying annotation to the proteoglycan catabolic process. ARSB&#39;s enzymatic removal of sulfate groups from chondroitin sulfate chains is a key step in proteoglycan degradation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                                        PMID:18285341
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                                        PMID:18285341
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1 and decorin, was significantly up-regulated following overexpression of ASB</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043202" target="_blank" class="term-link">
                                    GO:0043202
                                </a>
                            </span>
                            <span class="term-label">lysosomal lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-2282889
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0043202" data-r="Reactome:R-HSA-2282889" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation places ARSB in the lysosomal lumen based on Reactome pathway annotation for defective ARSB in MPS VI. The lysosomal lumen is indeed where ARSB functions to degrade glycosaminoglycans.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an accurate and specific cellular component annotation. ARSB is a soluble lysosomal enzyme that functions in the lysosomal lumen, where it encounters its substrates during glycosaminoglycan degradation. This is more specific than just &#34;lysosome&#34; and should be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The 47-kDa ASB form was located in dense lysosomes.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-2282889
                                    
                                </span>
                                
                                <div class="support-text">Defective ARSB does not hydrolyse C4S/C6S chains [implies ARSB functions in lysosomal lumen]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043202" target="_blank" class="term-link">
                                    GO:0043202
                                </a>
                            </span>
                            <span class="term-label">lysosomal lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-9036065
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0043202" data-r="Reactome:R-HSA-9036065" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is another TAS annotation for lysosomal lumen from a different Reactome pathway (defective ARSB not hydrolyzing dermatan sulfate). This is a duplicate of the previous annotation but from a different pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this is a duplicate GO term, it represents independent evidence from a different Reactome pathway, which reinforces the localization. It is acceptable to have the same term with different references.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-9036065
                                    
                                </span>
                                
                                <div class="support-text">Defective ARSB does not hydrolyse DS</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6798751
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0005576" data-r="Reactome:R-HSA-6798751" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation indicates ARSB is found in the extracellular region, specifically in the context of azurophil granule exocytosis from neutrophils. ARSB can be secreted and found extracellularly.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ARSB is primarily a lysosomal enzyme, it can be secreted and found in the extracellular region, particularly during neutrophil degranulation. This represents a non-core localization that is biologically relevant but secondary to the main lysosomal function. The annotation should be retained but marked as non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-6798751
                                    
                                </span>
                                
                                <div class="support-text">Exocytosis of azurophil granule lumen proteins [ARSB is among the proteins released]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">ARSB is predominantly a lysosomal enzyme. Extra-lysosomal [localizations exist]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6800434
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0005576" data-r="Reactome:R-HSA-6800434" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is another annotation for extracellular region from Reactome, this time in the context of ficolin-1-rich granule exocytosis. This is a duplicate GO term with different supporting evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This reinforces the extracellular localization through a different pathway (ficolin-rich granule exocytosis). As with the previous extracellular region annotation, this is a non-core localization but should be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-6800434
                                    
                                </span>
                                
                                <div class="support-text">Exocytosis of ficolin-rich granule lumen proteins [ARSB is among the proteins released]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035578" target="_blank" class="term-link">
                                    GO:0035578
                                </a>
                            </span>
                            <span class="term-label">azurophil granule lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6798751
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0035578" data-r="Reactome:R-HSA-6798751" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation places ARSB in azurophil granule lumen of neutrophils. Azurophil granules are specialized secretory granules in neutrophils that can contain lysosomal enzymes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a specialized, cell-type-specific localization of ARSB in neutrophils. While accurate, this represents a non-core localization specific to neutrophils and their degranulation processes. This should be retained as it is supported by Reactome but marked as non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-6798751
                                    
                                </span>
                                
                                <div class="support-text">Azurophil granules are generally described as spherical. Like lysosomes, they contain CD63 in their membrane (Cham et al. 1994) but are regarded as specialized secretory granules rather than lysosomes (Cieutat et al. 1998)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1904813" target="_blank" class="term-link">
                                    GO:1904813
                                </a>
                            </span>
                            <span class="term-label">ficolin-1-rich granule lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6800434
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:1904813" data-r="Reactome:R-HSA-6800434" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation places ARSB in ficolin-1-rich granule lumen, another type of secretory granule in neutrophils. This is a very specific, cell-type-restricted localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an extremely specific cellular compartment in neutrophils. While the annotation is supported by Reactome, it represents a highly specialized, non-core localization. It should be retained for completeness but clearly marked as non-core and cell-type-specific.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-6800434
                                    
                                </span>
                                
                                <div class="support-text">Exocytosis of ficolin-rich granule lumen proteins</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003943" target="_blank" class="term-link">
                                    GO:0003943
                                </a>
                            </span>
                            <span class="term-label">N-acetylgalactosamine-4-sulfatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19306108
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Arylsulfatase B regulates colonic epithelial cell migration ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0003943" data-r="PMID:19306108" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is another experimental (IDA) confirmation of ARSB&#39;s N-acetylgalactosamine-4-sulfatase activity from a different study. This study demonstrated that modulating ARSB expression affects chondroitin-4-sulfate content and related cellular functions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is independent experimental evidence for the core molecular function of ARSB. Having multiple IDA annotations from different studies strengthens the evidence for this critical activity. This should definitely be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                                        PMID:19306108
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009986" target="_blank" class="term-link">
                                    GO:0009986
                                </a>
                            </span>
                            <span class="term-label">cell surface</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0009986" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is an ISS (Inferred from Sequence Similarity) annotation for cell surface localization, based on orthology to rat ARSB (P50430). This reinforces the IEA annotation for cell surface localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is based on manual curation with sequence similarity to rat ARSB and represents higher quality evidence than pure IEA. Combined with the literature evidence for extra-lysosomal membrane localization of ARSB, this annotation should be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                                    
                                </span>
                                
                                <div class="support-text">Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Lysosome. Cell surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010632" target="_blank" class="term-link">
                                    GO:0010632
                                </a>
                            </span>
                            <span class="term-label">regulation of epithelial cell migration</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19306108
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Arylsulfatase B regulates colonic epithelial cell migration ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0010632" data-r="PMID:19306108" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This experimental annotation (IMP - Inferred from Mutant Phenotype) demonstrates that ARSB regulates epithelial cell migration. The study showed that silencing or overexpressing ARSB had inverse effects on colonic epithelial cell migration.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is high-quality experimental evidence showing that ARSB regulates epithelial cell migration through its effects on chondroitin sulfate content, MMP9 expression, and RhoA activation. While this is more of a regulatory role than the core enzymatic function, it represents an important biological function of ARSB and should be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                                        PMID:19306108
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">When ASB expression was silenced by siRNA in the NCM460 cells, [...] cell migration increased * 52%. Following overexpression of ASB, [...] cell migration decreased * 37%. These findings demonstrate marked effects of ASB expression on the migratory activity of colonic epithelial cells</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010976" target="_blank" class="term-link">
                                    GO:0010976
                                </a>
                            </span>
                            <span class="term-label">positive regulation of neuron projection development</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0010976" data-r="GO_REF:0000024" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is an ISS annotation for positive regulation of neuron projection development, based on rat ortholog. This duplicates the IEA annotation for the same term but with manual curation evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This ISS annotation provides stronger evidence than the IEA annotation for the same term. As discussed previously, this represents a non-core, tissue-specific function of ARSB in the nervous system. The annotation should be retained but marked as non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0061580" target="_blank" class="term-link">
                                    GO:0061580
                                </a>
                            </span>
                            <span class="term-label">colon epithelial cell migration</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19306108
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Arylsulfatase B regulates colonic epithelial cell migration ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0061580" data-r="PMID:19306108" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This experimental annotation (IMP) demonstrates that ARSB affects colon epithelial cell migration specifically. This is a more specific term than the general &#34;regulation of epithelial cell migration&#34; annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is high-quality experimental evidence for a specific tissue type (colon) and represents an important biological function of ARSB. While more specific than the general epithelial cell migration term, this level of specificity is valuable and should be retained as it reflects the actual experimental system used.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                                        PMID:19306108
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In the T84 cell line, derived from lung metastasis of malignant colonic epithelial cells, [...] In the T84 cells, matrix metalloproteinase 9 (MMP9), activated RhoA, and cell migration, as well as C4S content, were significantly more than in the NCM460 cells. Silencing and overexpression of ASB had inverse effects on MMP9, activated RhoA, and cell migration</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23533145
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    In-depth proteomic analyses of exosomes isolated from expres...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0070062" data-r="PMID:23533145" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation indicates ARSB is found in extracellular exosomes, based on high-throughput detection assay (HDA) from a proteomic study of exosomes in urine.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is based on proteomic detection of ARSB in exosomes. While this is a legitimate localization, it represents a non-core aspect of ARSB biology. Many proteins can be found in exosomes, and this may reflect secretion or release mechanisms rather than a primary functional localization. The annotation should be retained as it is experimentally supported, but marked as non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link">
                                        PMID:23533145
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine [ARSB was detected in exosomes]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005788" target="_blank" class="term-link">
                                    GO:0005788
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1614362
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0005788" data-r="Reactome:R-HSA-1614362" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation places ARSB in the ER lumen, based on Reactome pathway for SUMF1-mediated oxidation of cysteine to formylglycine. This post-translational modification occurs in the ER during ARSB biosynthesis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation reflects a transient localization during ARSB biosynthesis and maturation, not the functional localization. The formylglycine modification by SUMF1 occurs in the ER, after which ARSB is trafficked to lysosomes. This should be retained as it reflects an important aspect of ARSB biology (the post-translational modification required for activity), but marked as non-core since it is a biosynthetic intermediate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1614362
                                    
                                </span>
                                
                                <div class="support-text">SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">PTM: The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic activity.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043202" target="_blank" class="term-link">
                                    GO:0043202
                                </a>
                            </span>
                            <span class="term-label">lysosomal lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1606789
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0043202" data-r="Reactome:R-HSA-1606789" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is another TAS annotation for lysosomal lumen from Reactome pathway &#34;ARSB hydrolyses DS&#34;. This is a third annotation for the same GO term from a different Reactome pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This reinforces the lysosomal lumen localization through another Reactome pathway focused on dermatan sulfate degradation. While duplicate, multiple annotations from different pathways strengthen the evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1606789
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043202" target="_blank" class="term-link">
                                    GO:0043202
                                </a>
                            </span>
                            <span class="term-label">lysosomal lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1793207
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0043202" data-r="Reactome:R-HSA-1793207" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a fourth TAS annotation for lysosomal lumen from Reactome pathway &#34;ARSB hydrolyses C4S/C6S chains&#34;. This is yet another duplicate from a different pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This reinforces the lysosomal lumen localization through the chondroitin sulfate degradation pathway. Multiple pathway annotations strengthen the evidence for this core localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1793207
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004065" target="_blank" class="term-link">
                                    GO:0004065
                                </a>
                            </span>
                            <span class="term-label">arylsulfatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:2303452
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phylogenetic conservation of arylsulfatases. cDNA cloning an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0004065" data-r="PMID:2303452" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a TAS (Traceable Author Statement) annotation for arylsulfatase activity from the seminal 1990 paper that cloned and characterized human ARSB. This provides experimental literature support for the arylsulfatase classification.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a foundational reference for ARSB characterization and provides strong experimental support for the arylsulfatase activity annotation. This should definitely be retained as it represents the original biochemical characterization of the enzyme.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. [...] Overexpression of ASB in transfected baby hamster kidney (BHK) cells resulted in up to 68-fold higher ASB activity</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005764" target="_blank" class="term-link">
                                    GO:0005764
                                </a>
                            </span>
                            <span class="term-label">lysosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:2303452
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phylogenetic conservation of arylsulfatases. cDNA cloning an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0005764" data-r="PMID:2303452" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a TAS annotation for lysosome localization from the same foundational 1990 paper. This provides experimental literature support for the lysosomal localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is strong experimental evidence from the original characterization of ARSB showing its lysosomal localization and mannose-6-phosphate receptor-mediated trafficking. This is core evidence that should definitely be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007040" target="_blank" class="term-link">
                                    GO:0007040
                                </a>
                            </span>
                            <span class="term-label">lysosome organization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/1718978" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:1718978
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An inter...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0007040" data-r="PMID:1718978" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in lysosome organization. The reference is to a 1991 paper about MPS VI mutations, which describes the disease phenotype but does not directly demonstrate that ARSB organizes lysosomes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This appears to be a misannotation. While ARSB deficiency leads to lysosomal storage disease (MPS VI), this does not mean ARSB&#39;s primary function is to organize lysosomes. ARSB is a lysosomal enzyme that degrades glycosaminoglycans; its absence causes substrate accumulation and lysosomal dysfunction, but this is a consequence of enzyme deficiency, not evidence that ARSB actively organizes lysosomes. This annotation should be removed.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/1718978" target="_blank" class="term-link">
                                        PMID:1718978
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI) is a lysosomal storage disease with autosomal recessive inheritance caused by deficiency of the enzyme arylsulfatase B. [This describes disease, not lysosome organization activity]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007041" target="_blank" class="term-link">
                                    GO:0007041
                                </a>
                            </span>
                            <span class="term-label">lysosomal transport</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:2303452
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phylogenetic conservation of arylsulfatases. cDNA cloning an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0007041" data-r="PMID:2303452" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests ARSB is involved in lysosomal transport. The reference describes ARSB being transported TO lysosomes via the mannose-6-phosphate receptor pathway, not that ARSB performs transport functions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a misannotation. The reference describes ARSB as a cargo being transported to lysosomes, not as performing transport functions. ARSB is a lysosomal enzyme that degrades substrates; it does not transport materials. This annotation confuses the trafficking of ARSB to lysosomes with ARSB having a transport function. This should be removed.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                        PMID:2303452
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner. [This describes transport OF ARSB, not transport BY ARSB]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030209" target="_blank" class="term-link">
                                    GO:0030209
                                </a>
                            </span>
                            <span class="term-label">dermatan sulfate proteoglycan catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1606789
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0030209" data-r="Reactome:R-HSA-1606789" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ARSB is directly involved in dermatan sulfate degradation by removing 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues. This is one of the primary catabolic pathways in which ARSB participates, as documented in Reactome and the cyberian deep research.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This biological process annotation is missing from the existing GOA file but is a core function of ARSB. Dermatan sulfate is one of two primary substrates for ARSB, and its degradation is blocked in MPS VI patients. This annotation is well-supported by Reactome pathway documentation and literature.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1606789
                                    
                                </span>
                                
                                <div class="support-text">Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate (DS; Gorham &amp; Cantz 1978)</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-cyberian.md
                                    
                                </span>
                                
                                <div class="support-text">ARSB acts specifically on two major sulfated glycosaminoglycans: Dermatan sulfate (DS): A heteropolysaccharide composed of repeating disaccharide units containing iduronic acid and N-acetylgalactosamine-4-sulfate</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006027" target="_blank" class="term-link">
                                    GO:0006027
                                </a>
                            </span>
                            <span class="term-label">glycosaminoglycan catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1606789
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15848" data-a="GO:0006027" data-r="Reactome:R-HSA-1606789" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ARSB participates in the broader glycosaminoglycan catabolic process through its specific role in degrading dermatan sulfate and chondroitin-4-sulfate. This is the parent process that encompasses the more specific DS and C4S catabolic activities.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This biological process annotation represents the broader catabolic category encompassing ARSB function. While more general than the specific dermatan sulfate or chondroitin sulfate proteoglycan catabolic processes, it appropriately captures ARSB&#39;s role in GAG catabolism. The annotation is supported by Reactome pathway documentation and literature.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-1606789
                                    
                                </span>
                                
                                <div class="support-text">Defects in ARSB are the cause of mucopolysaccharidosis type VI (MPSVI) (MIM:253200, also called Maroteaux-Lamy syndrome</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-deep-research-cyberian.md
                                    
                                </span>
                                
                                <div class="support-text">ARSB functions within the lysosomal catabolism pathway for sulfated glycosaminoglycans. The sequential degradation of dermatan sulfate and chondroitin sulfate requires multiple enzymes acting in a specific order.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ARSB/ARSB-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">DISEASE: Mucopolysaccharidosis 6 (MPS6) [MIM:253200]: A form of mucopolysaccharidosis, a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Hydrolyzing 4-sulfate groups from N-acetylgalactosamine residues within dermatan sulfate and chondroitin-4-sulfate glycosaminoglycan chains in the lysosomal lumen</h3>
                <span class="vote-buttons" data-g="P15848" data-a="FUNCTION: Hydrolyzing 4-sulfate groups from N-acetylgalactos..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003943" target="_blank" class="term-link">
                            N-acetylgalactosamine-4-sulfatase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030209" target="_blank" class="term-link">
                                dermatan sulfate proteoglycan catabolic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030207" target="_blank" class="term-link">
                                chondroitin sulfate proteoglycan catabolic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006027" target="_blank" class="term-link">
                                glycosaminoglycan catabolic process
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043202" target="_blank" class="term-link">
                                lysosomal lumen
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
                <div class="function-term-group">
                    <div class="function-term-label">Substrates:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:18376" target="_blank" class="term-link">
                                dermatan sulfate
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:18250" target="_blank" class="term-link">
                                chondroitin 4&#39;-sulfate
                            </a>
                        </span>
                        
                    </div>
                </div>
                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                                PMID:19306108
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S).</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                                PMID:18285341
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            Reactome:R-HSA-1606789
                            
                        </span>
                        
                        <div class="finding-text">Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate (DS)</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            Reactome:R-HSA-1793207
                            
                        </span>
                        
                        <div class="finding-text">Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                                PMID:2303452
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/ARSB/ARSB-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/ARSB/ARSB-deep-research-cyberian.md
                            
                        </span>
                        
                        <div class="finding-text">The crystal structure of human ARSB (PDB: 1FSU), solved at 2.5 A resolution, revealed that: Formylglycine (FGly91) is found in a sulfate-modified form (oxo-alanine sulfate ester) in the active site; A divalent calcium ion (Ca2+) is coordinated at the active site and is essential for catalysis</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/ARSB/ARSB-deep-research-cyberian.md
                            
                        </span>
                        
                        <div class="finding-text">The sulfate hydrolysis mechanism proceeds through either an addition-hydrolysis (AH) or transesterification-elimination (TE) pathway, with current evidence favoring the TE mechanism.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000003.md" target="_blank" class="term-link">
                            GO_REF:0000003
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on Enzyme Commission mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000024.md" target="_blank" class="term-link">
                            GO_REF:0000024
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/1718978" target="_blank" class="term-link">
                            PMID:1718978
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">The G137V mutation in ARSB severely reduces stability of the precursor protein</div>
                        
                        <div class="finding-text">"The G137V mutation did not affect the synthesis but severely reduced the stability of the arylsulfatase B precursor."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Most of the mutant precursor is degraded before reaching lysosomes</div>
                        
                        <div class="finding-text">"the majority of the mutant precursor was degraded presumably in a compartment proximal to the trans Golgi network and only a small amount escaped to the lysosomes"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">This mutation causes an intermediate form of MPS VI</div>
                        
                        <div class="finding-text">"accounting for the low residual enzyme activity in fibroblasts of a patient with the juvenile form of the disease."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18285341" target="_blank" class="term-link">
                            PMID:18285341
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB (N-acetylgalactosamine-4-sulfatase) hydrolyzes sulfate groups from chondroitin sulfate</div>
                        
                        <div class="finding-text">"The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Silencing ARSB increases chondroitin-4-sulfate, total chondroitin sulfate, and total sulfated GAG content</div>
                        
                        <div class="finding-text">"Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Overexpressing ARSB decreases chondroitin-4-sulfate and total chondroitin sulfate</div>
                        
                        <div class="finding-text">"Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB expression affects proteoglycan core protein expression (syndecan-1, decorin)</div>
                        
                        <div class="finding-text">"mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1 and decorin, was significantly up-regulated following overexpression of ASB"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19306108" target="_blank" class="term-link">
                            PMID:19306108
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate in chondroitin-4-sulfate</div>
                        
                        <div class="finding-text">"Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB activity is significantly lower in malignant T84 colonic cells compared to normal colonocytes</div>
                        
                        <div class="finding-text">"In the T84 cell line, derived from lung metastasis of malignant colonic epithelial cells, the activity of ASB, as well as steroid sulfatase, arylsulfatase A, and galactose-6-sulfatase, were significantly less than in normal, primary colonic epithelial cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Silencing ARSB increases MMP9 secretion, activated RhoA, and cell migration</div>
                        
                        <div class="finding-text">"When ASB expression was silenced by siRNA in the NCM460 cells, MMP9 secretion increased to over 3 times the basal level, activated RhoA increased * 85%, and cell migration increased * 52%."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Overexpressing ARSB decreases MMP9, activated RhoA, and cell migration</div>
                        
                        <div class="finding-text">"Following overexpression of ASB, MMP9 declined 51%, activated RhoA declined * 51%, and cell migration decreased * 37%."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB regulates invasive phenotype of colonic epithelial cells through effects on chondroitin sulfation</div>
                        
                        <div class="finding-text">"These findings demonstrate marked effects of ASB expression on the migratory activity of colonic epithelial cells, activated RhoA, and MMP9, and suggest a potential vital role of ASB, due to its impact on chondroitin sulfation, on determination of the invasive phenotype of colonic epithelial cells."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/2303452" target="_blank" class="term-link">
                            PMID:2303452
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Human ARSB is a 533 amino acid protein with a 41 amino acid signal peptide</div>
                        
                        <div class="finding-text">"The deduced amino acid sequence of 533 amino acids contains a 41-amino acid N-terminal signal peptide and a mature polypeptide of 492 amino acid residues."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is synthesized as a 64-kDa precursor and processed to a 47-kDa mature form</div>
                        
                        <div class="finding-text">"Pulse-chase labeling showed that ASB was synthesized and secreted as a 64-kDa precursor and processed to a 47-kDa mature form in BHK cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB localizes to dense lysosomes via mannose-6-phosphate receptor-dependent trafficking</div>
                        
                        <div class="finding-text">"The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is a member of the arylsulfatase gene family showing phylogenetic conservation</div>
                        
                        <div class="finding-text">"Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity suggesting that they arose from a common ancestral gene and are members of an arylsulfatase gene family."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link">
                            PMID:23533145
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB was detected in exosomes from prostatic secretions by proteomic analysis</div>
                        
                        <div class="finding-text">"In pooled EPS-urine exosome samples, ~900 proteins were detected [including ARSB]"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-1606789
                        
                    </span>
                </div>
                
                <div class="reference-title">ARSB hydrolyses DS</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB hydrolyzes sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate</div>
                        
                        <div class="finding-text">"Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate (DS; Gorham &amp; Cantz 1978)"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Conversion of cysteine to 3-oxoalanine (formylglycine) is critical for catalytic activity</div>
                        
                        <div class="finding-text">"The conversion to 3-oxoalanine (formylglycine, FGly) of a cysteine residue in eukaryotes, is critical for catalytic activity"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Defects in ARSB cause mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)</div>
                        
                        <div class="finding-text">"Defects in ARSB are the cause of mucopolysaccharidosis type VI (MPSVI) (MIM:253200, also called Maroteaux-Lamy syndrome (Wicker et al. 1991)"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-1614362
                        
                    </span>
                </div>
                
                <div class="reference-title">SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">SUMF1 performs post-translational modification of ARSB required for activity</div>
                        
                        <div class="finding-text">"SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">This modification occurs during ARSB biosynthesis</div>
                        
                        <div class="finding-text">"SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases [during biosynthesis]"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-1793207
                        
                    </span>
                </div>
                
                <div class="reference-title">ARSB hydrolyses C4S/C6S chains</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB with calcium cofactor hydrolyzes sulfate from N-acetylgalactosamine 4-sulfate or 6-sulfate units in chondroitin sulfate</div>
                        
                        <div class="finding-text">"Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Formylglycine modification is critical for catalytic activity</div>
                        
                        <div class="finding-text">"The conversion to 3-oxoalanine (formylglycine, FGly) of a cysteine residue in eukaryotes, is critical for catalytic activity, based on similarity to the prototypical arylsulfatase ARSA"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-2282889
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective ARSB does not hydrolyse C4S/C6S chains</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Loss of ARSB function prevents degradation of chondroitin sulfate chains</div>
                        
                        <div class="finding-text">"Defective ARSB does not hydrolyse C4S/C6S chains"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">This leads to MPS VI pathology</div>
                        
                        <div class="finding-text">"Defective ARSB does not hydrolyse C4S/C6S chains [leading to MPS VI]"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6798751
                        
                    </span>
                </div>
                
                <div class="reference-title">Exocytosis of azurophil granule lumen proteins</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is present in azurophil granules of neutrophils</div>
                        
                        <div class="finding-text">"Exocytosis of azurophil granule lumen proteins"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">These granules can undergo exocytosis, releasing ARSB extracellularly</div>
                        
                        <div class="finding-text">"Exocytosis of azurophil granule lumen proteins"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6800434
                        
                    </span>
                </div>
                
                <div class="reference-title">Exocytosis of ficolin-rich granule lumen proteins</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is present in ficolin-1-rich granules</div>
                        
                        <div class="finding-text">"Exocytosis of ficolin-rich granule lumen proteins [ARSB is present]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">These specialized neutrophil granules can release ARSB through exocytosis</div>
                        
                        <div class="finding-text">"Exocytosis of ficolin-rich granule lumen proteins"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-9036065
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective ARSB does not hydrolyse DS</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Loss of ARSB function prevents degradation of dermatan sulfate</div>
                        
                        <div class="finding-text">"Defective ARSB does not hydrolyse DS"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">This contributes to MPS VI pathology</div>
                        
                        <div class="finding-text">"Defective ARSB does not hydrolyse DS [contributing to MPS VI pathology]"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/ARSB/ARSB-uniprot.txt
                        
                    </span>
                </div>
                
                <div class="reference-title">UniProt entry for ARSB (P15848)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB removes sulfate groups from chondroitin-4-sulfate and regulates its degradation</div>
                        
                        <div class="finding-text">"Removes sulfate groups from chondroitin-4-sulfate (C4S) and regulates its degradation"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Involved in regulation of cell adhesion, cell migration, and invasion in colonic epithelium</div>
                        
                        <div class="finding-text">"Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Regulates neurite outgrowth and neuronal plasticity in CNS through control of sulfate GAGs and neurocan</div>
                        
                        <div class="finding-text">"In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Requires calcium cofactor (binds 1 Ca2+ per subunit)</div>
                        
                        <div class="finding-text">"COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Conversion of Cys-91 to 3-oxoalanine (formylglycine) is critical for catalytic activity</div>
                        
                        <div class="finding-text">"The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic activity."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Deficiency causes mucopolysaccharidosis type VI (MPS VI)</div>
                        
                        <div class="finding-text">"DISEASE: Mucopolysaccharidosis 6 (MPS6) [MIM:253200]: A form of mucopolysaccharidosis, a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/ARSB/ARSB-deep-research-perplexity-lite.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on ARSB gene</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is predominantly a lysosomal enzyme with extra-lysosomal localization at cell membranes in some cell types</div>
                        
                        <div class="finding-text">"Primary: ARSB is predominantly a lysosomal enzyme. Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also detected ARSB at the cell membrane"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB regulates extracellular matrix remodeling, cell migration, and signaling pathways</div>
                        
                        <div class="finding-text">"Extracellular matrix remodeling: ARSB influences the composition and turnover of the extracellular matrix, affecting cell adhesion, migration, and invasion"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB has tumor suppressor activity; reduced expression linked to cancer progression</div>
                        
                        <div class="finding-text">"Cancer: Reduced ARSB expression is linked to altered proteoglycan expression and tumor progression in prostate and colonic epithelial cells. Acts as a tumor suppressor"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB regulates neuronal development through control of sulfated GAGs and neurocan</div>
                        
                        <div class="finding-text">"Neuronal development: In the central nervous system, ARSB regulates neurite outgrowth and neuronal plasticity by controlling sulfate GAG and neurocan levels"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Enzyme replacement therapy with recombinant ARSB is standard treatment for MPS VI</div>
                        
                        <div class="finding-text">"Enzyme replacement therapy (ERT) with recombinant ARSB is the standard treatment for MPS VI, aiming to reduce GAG accumulation and ameliorate symptoms"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/ARSB/ARSB-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on ARSB gene (cyberian)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB catalyzes removal of 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues at the non-reducing end of GAG chains</div>
                        
                        <div class="finding-text">"Arylsulfatase B (ARSB) is a sulfohydrolase that catalyzes the removal of 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues located at the non-reducing end of glycosaminoglycan (GAG) chains. The systematic name of the enzyme is N-acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase (Bond et al., 1997; Valayannopoulos et al., 2010)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB also demonstrates activity against N-acetylglucosamine-4-sulfate as a substrate</div>
                        
                        <div class="finding-text">"Notably, ARSB also demonstrates activity against N-acetylglucosamine-4-sulfate as a substrate (Bond et al., 1997). This activity is consistent with the enzyme&#39;s ability to act on related 4-sulfated hexosamine residues, though its primary physiological substrates remain the GAG chains of DS and C4S."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Formylglycine (FGly91) is found in a sulfate-modified form at the active site, and calcium ion is essential for catalysis</div>
                        
                        <div class="finding-text">"The crystal structure of human ARSB (PDB: 1FSU), solved at 2.5 A resolution, revealed that: Formylglycine (FGly91) is found in a sulfate-modified form (oxo-alanine sulfate ester) in the active site; A divalent calcium ion (Ca2+) is coordinated at the active site and is essential for catalysis; The calcium ion binds directly to the sulfate group of the modified cysteine residue (Bond et al., 1997)"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Sulfate hydrolysis proceeds through transesterification-elimination (TE) mechanism</div>
                        
                        <div class="finding-text">"The sulfate hydrolysis mechanism proceeds through either an addition-hydrolysis (AH) or transesterification-elimination (TE) pathway, with current evidence favoring the TE mechanism. In this mechanism: The aldehyde of formylglycine becomes hydrated to a gem-diol; One hydroxyl of the gem-diol attacks the substrate sulfur, forming a covalent enzyme-sulfate intermediate; Elimination releases the product and regenerates the aldehyde (Hanson et al., 2004)"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB is targeted to lysosomes via the mannose-6-phosphate (M6P) receptor pathway</div>
                        
                        <div class="finding-text">"The mature enzyme of 533 amino acids is generated after cleavage of the signal peptide and is targeted to lysosomes via the mannose-6-phosphate (M6P) receptor pathway (Braulke &amp; Bonifacino, 2009)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB participates in extracellular GAG remodeling at the plasma membrane and in the extracellular matrix</div>
                        
                        <div class="finding-text">"While primarily a lysosomal enzyme, ARSB also exhibits extra-lysosomal localization. Studies have demonstrated ARSB presence at the plasma membrane and in the extracellular matrix, where it participates in local GAG remodeling (Bhattacharyya et al., 2009)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB modulates galectin-3 binding and SHP-2 phosphatase activity through control of chondroitin sulfation</div>
                        
                        <div class="finding-text">"Beyond its housekeeping role in GAG catabolism, ARSB has emerged as a regulator of cellular signaling and gene expression. By controlling the sulfation status of cell-surface and extracellular GAGs, ARSB modulates: Galectin-3 binding: The degree of chondroitin 4-sulfation affects galectin-3 sequestration and release, influencing downstream signaling; SHP-2 phosphatase activity: ARSB activity impacts SHP-2 localization and function (Bhattacharyya et al., 2022)"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ARSB functions as a tumor suppressor, transcriptional mediator, and regulator of cellular signaling</div>
                        
                        <div class="finding-text">"These broader roles suggest ARSB functions as a tumor suppressor, transcriptional mediator, and regulator of cellular signaling beyond its classical lysosomal function."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">The ARSB protein structure contains an active site domain resembling alkaline phosphatase</div>
                        
                        <div class="finding-text">"Despite lacking detectable sequence similarity, the ARSB active site domain closely resembles that of alkaline phosphatase. The calcium in ARSB superimposes on one of the zinc ions in alkaline phosphatase, and the oxo-alanine sulfate ester superimposes on the phosphate ion in alkaline phosphatase (Bond et al., 1997)"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Over 220 unique ARSB variants have been identified causing MPS VI</div>
                        
                        <div class="finding-text">"Genetic heterogeneity: Over 220 unique ARSB variants have been identified, including Missense variants: 59.5%, Small deletions: 13.5%, Nonsense mutations: 12.0%, Splice site variants: 5.0%"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ARSB-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15848" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-15T16:26:40.233942'<br />
end_time: '2026-01-15T17:06:46.500681'<br />
duration_seconds: 2406.27<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: ARSB<br />
  gene_symbol: ARSB<br />
  uniprot_accession: P15848<br />
  protein_description: 'RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12; AltName:<br />
    Full=N-acetylgalactosamine-4-sulfatase; Short=G4S; Flags: Precursor;'<br />
  gene_info: Name=ARSB;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the sulfatase family. .<br />
  protein_domains: Alkaline_phosphatase_core_sf. (IPR017850); ARSB. (IPR047115); Sulfatase_CS.<br />
    (IPR024607); Sulfatase_N. (IPR000917); Sulfatase (PF00884)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 5</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> P15848</li>
<li><strong>Protein Description:</strong> RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12; AltName: Full=N-acetylgalactosamine-4-sulfatase; Short=G4S; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=ARSB;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the sulfatase family. .</li>
<li><strong>Key Domains:</strong> Alkaline_phosphatase_core_sf. (IPR017850); ARSB. (IPR047115); Sulfatase_CS. (IPR024607); Sulfatase_N. (IPR000917); Sulfatase (PF00884)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ARSB" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ARSB' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ARSB</strong> (gene ID: ARSB, UniProt: P15848) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="comprehensive-research-report-arsb-arylsulfatase-b">Comprehensive Research Report: ARSB (Arylsulfatase B)</h1>
<h2 id="geneprotein-identity-verification">Gene/Protein Identity Verification</h2>
<p><strong>UniProt Accession:</strong> P15848<br />
<strong>Protein Names:</strong> Arylsulfatase B (ASB); N-acetylgalactosamine-4-sulfatase (G4S)<br />
<strong>EC Number:</strong> 3.1.6.12<br />
<strong>Gene Symbol:</strong> ARSB<br />
<strong>Chromosomal Location:</strong> 5q14.1<br />
<strong>Organism:</strong> Homo sapiens (Human)<br />
<strong>Protein Family:</strong> Sulfatase family<br />
<strong>Key Domains:</strong> Sulfatase_N (IPR000917), Sulfatase (PF00884), Alkaline_phosphatase_core_sf (IPR017850)</p>
<p>The identity of ARSB has been unambiguously verified through multiple authoritative databases and extensive primary literature. ARSB encodes a lysosomal sulfatase enzyme whose deficiency causes the well-characterized lysosomal storage disorder Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).</p>
<hr />
<h2 id="1-enzymatic-function-and-catalytic-mechanism">1. Enzymatic Function and Catalytic Mechanism</h2>
<h3 id="11-reaction-catalyzed">1.1 Reaction Catalyzed</h3>
<p>Arylsulfatase B (ARSB) is a sulfohydrolase that catalyzes the removal of 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues located at the non-reducing end of glycosaminoglycan (GAG) chains. The systematic name of the enzyme is N-acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase (Bond et al., 1997; Valayannopoulos et al., 2010).</p>
<p>The reaction catalyzed is:</p>
<div class="codehilite"><pre><span></span><code>N-acetyl-D-galactosamine-4-sulfate + H2O ‚Üí N-acetyl-D-galactosamine + sulfate
</code></pre></div>

<p>This hydrolytic cleavage of the sulfate ester bond is essential for the sequential degradation of the glycosaminoglycans dermatan sulfate (DS) and chondroitin 4-sulfate (C4S) within lysosomes (Tomatsu et al., 2021).</p>
<h3 id="12-substrate-specificity">1.2 Substrate Specificity</h3>
<p>ARSB acts specifically on two major sulfated glycosaminoglycans:</p>
<ol>
<li><strong>Dermatan sulfate (DS):</strong> A heteropolysaccharide composed of repeating disaccharide units containing iduronic acid and N-acetylgalactosamine-4-sulfate</li>
<li><strong>Chondroitin 4-sulfate (C4S):</strong> A related glycosaminoglycan containing glucuronic acid instead of iduronic acid</li>
</ol>
<p>The enzyme exhibits strict positional specificity, exclusively hydrolyzing the 4-O-sulfate ester bond on N-acetylgalactosamine residues. Notably, ARSB also demonstrates activity against N-acetylglucosamine-4-sulfate as a substrate (Bond et al., 1997). This activity is consistent with the enzyme's ability to act on related 4-sulfated hexosamine residues, though its primary physiological substrates remain the GAG chains of DS and C4S.</p>
<h3 id="13-catalytic-mechanism-and-active-site">1.3 Catalytic Mechanism and Active Site</h3>
<p>The catalytic mechanism of ARSB requires a unique post-translational modification: the conversion of a critical cysteine residue (Cys91) to formylglycine (3-oxoalanine or FGly). This modification is catalyzed by the formylglycine-generating enzyme (FGE/SUMF1) and is essential for activity of all type I sulfatases (Dierks et al., 2003; Preusser-Kunze et al., 2005).</p>
<p>The crystal structure of human ARSB (PDB: 1FSU), solved at 2.5 √Ö resolution, revealed that:</p>
<ul>
<li><strong>Formylglycine (FGly91)</strong> is found in a sulfate-modified form (oxo-alanine sulfate ester) in the active site</li>
<li><strong>A divalent calcium ion (Ca¬≤‚Å∫)</strong> is coordinated at the active site and is essential for catalysis</li>
<li>The calcium ion binds directly to the sulfate group of the modified cysteine residue (Bond et al., 1997)</li>
</ul>
<p>The sulfate hydrolysis mechanism proceeds through either an addition-hydrolysis (AH) or transesterification-elimination (TE) pathway, with current evidence favoring the TE mechanism. In this mechanism:</p>
<ol>
<li>The aldehyde of formylglycine becomes hydrated to a gem-diol</li>
<li>One hydroxyl of the gem-diol attacks the substrate sulfur, forming a covalent enzyme-sulfate intermediate</li>
<li>Elimination releases the product and regenerates the aldehyde (Hanson et al., 2004)</li>
</ol>
<p>The requirement for molecular oxygen in the formation of formylglycine explains why sulfatase activity is oxygen-dependent during enzyme biosynthesis.</p>
<hr />
<h2 id="2-subcellular-localization">2. Subcellular Localization</h2>
<h3 id="21-lysosomal-targeting">2.1 Lysosomal Targeting</h3>
<p>ARSB is synthesized as a precursor protein containing a signal peptide that directs it to the endoplasmic reticulum (ER). The mature enzyme of 533 amino acids is generated after cleavage of the signal peptide and is targeted to lysosomes via the mannose-6-phosphate (M6P) receptor pathway (Braulke &amp; Bonifacino, 2009).</p>
<p>The lysosomal targeting mechanism involves:</p>
<ol>
<li><strong>N-glycosylation:</strong> ARSB undergoes N-linked glycosylation in the ER</li>
<li><strong>Phosphorylation:</strong> In the cis-Golgi network, the enzyme UDP-N-acetylglucosamine 1-phosphotransferase recognizes lysosomal hydrolases and adds N-acetylglucosamine-1-phosphate to specific mannose residues</li>
<li><strong>M6P tag generation:</strong> A second enzyme removes the N-acetylglucosamine, exposing the mannose-6-phosphate recognition marker</li>
<li><strong>Receptor binding:</strong> In the trans-Golgi network, ARSB binds to either the cation-independent M6P receptor (CI-MPR, ~300 kDa) or the cation-dependent M6P receptor (CD-MPR, ~46 kDa)</li>
<li><strong>Delivery:</strong> The receptor-enzyme complexes are transported to late endosomes/lysosomes via clathrin-coated vesicles, where the acidic pH induces dissociation (Ghosh et al., 2003)</li>
</ol>
<h3 id="22-extracellular-localization">2.2 Extracellular Localization</h3>
<p>While primarily a lysosomal enzyme, ARSB also exhibits extra-lysosomal localization. Studies have demonstrated ARSB presence at the plasma membrane and in the extracellular matrix, where it participates in local GAG remodeling (Bhattacharyya et al., 2009). This extra-lysosomal activity appears particularly important for:</p>
<ul>
<li>Regulation of chondroitin sulfate proteoglycan turnover in the extracellular matrix</li>
<li>Modulation of cell signaling through control of sulfated GAG-protein interactions</li>
</ul>
<p>The enzyme can also be secreted and recaptured by cells via the M6P receptor pathway, a phenomenon that forms the basis of enzyme replacement therapy (Sly et al., 1978).</p>
<hr />
<h2 id="3-biological-processes-and-pathways">3. Biological Processes and Pathways</h2>
<h3 id="31-glycosaminoglycan-degradation-pathway">3.1 Glycosaminoglycan Degradation Pathway</h3>
<p>ARSB functions within the lysosomal catabolism pathway for sulfated glycosaminoglycans. The sequential degradation of dermatan sulfate and chondroitin sulfate requires multiple enzymes acting in a specific order, as each enzyme is strictly substrate-specific and there is no functional redundancy (Coutinho et al., 2012).</p>
<p>The degradation sequence for dermatan sulfate involves:</p>
<ol>
<li><strong>Endolytic cleavage:</strong> Hyaluronidases (particularly HYAL1 and HYAL4) initially cleave the GAG polymer into oligosaccharides</li>
<li><strong>Exolytic processing:</strong> Sequential removal of terminal residues by specific exoenzymes:</li>
<li><strong>Iduronate-2-sulfatase (IDS):</strong> Removes 2-O-sulfate from iduronic acid residues</li>
<li><strong>Œ±-L-iduronidase (IDUA):</strong> Cleaves unsulfated iduronic acid</li>
<li><strong>ARSB:</strong> Removes 4-O-sulfate from N-acetylgalactosamine</li>
<li><strong>Œ≤-hexosaminidase:</strong> Cleaves N-acetylgalactosamine</li>
</ol>
<p>For chondroitin 4-sulfate, the pathway is similar but involves glucuronidase instead of iduronidase for uronic acid cleavage.</p>
<p>The blockade of this pathway at the ARSB step results in accumulation of partially degraded dermatan sulfate and chondroitin 4-sulfate within lysosomes, leading to cellular dysfunction and the clinical manifestations of MPS VI (Valayannopoulos et al., 2010).</p>
<h3 id="32-tissue-specific-gag-accumulation">3.2 Tissue-Specific GAG Accumulation</h3>
<p>Importantly, even within MPS VI, GAG accumulation shows tissue-specific patterns:</p>
<ul>
<li><strong>Hepatocytes:</strong> Approximately 80% of accumulated GAGs are iduronate-rich dermatan sulfate</li>
<li><strong>Bone and kidney cells:</strong> Up to 90% of accumulated GAGs are glucuronate-rich chondroitin sulfate (Monta√±o et al., 2007)</li>
</ul>
<p>This differential accumulation suggests that abnormal chondroitin sulfate metabolism plays a particularly important role in the skeletal manifestations of MPS VI.</p>
<h3 id="33-broader-regulatory-functions">3.3 Broader Regulatory Functions</h3>
<p>Beyond its housekeeping role in GAG catabolism, ARSB has emerged as a regulator of cellular signaling and gene expression. By controlling the sulfation status of cell-surface and extracellular GAGs, ARSB modulates:</p>
<ol>
<li><strong>Galectin-3 binding:</strong> The degree of chondroitin 4-sulfation affects galectin-3 sequestration and release, influencing downstream signaling</li>
<li><strong>SHP-2 phosphatase activity:</strong> ARSB activity impacts SHP-2 localization and function</li>
<li><strong>Wnt/Œ≤-catenin signaling:</strong> Through effects on chondroitin sulfate proteoglycans</li>
<li><strong>Transcriptional regulation:</strong> ARSB-mediated changes in chondroitin sulfation influence transcription factor activity and chromatin remodeling (Bhattacharyya et al., 2022)</li>
</ol>
<p>These broader roles suggest ARSB functions as a tumor suppressor, transcriptional mediator, and regulator of cellular signaling beyond its classical lysosomal function.</p>
<hr />
<h2 id="4-structural-biology">4. Structural Biology</h2>
<h3 id="41-gene-and-protein-structure">4.1 Gene and Protein Structure</h3>
<p>The human <em>ARSB</em> gene is located on chromosome 5q14.1, spans approximately 208 kb, and contains 8 exons. The full-length transcript of 4,852 bp encodes a precursor protein that is processed to the mature 533-amino acid enzyme (Tomatsu et al., 2021).</p>
<p>The ARSB protein consists of two domains:</p>
<ol>
<li><strong>Large N-terminal domain:</strong> Contains the active site and belongs to the Œ±/Œ≤ class of proteins. This domain features a 10-stranded mixed Œ≤-sheet flanked by Œ±-helices. The active site is located in a cleft at the C-terminal end of this large Œ≤-sheet.</li>
<li><strong>Smaller C-terminal domain:</strong> Contributes to overall protein stability</li>
</ol>
<h3 id="42-crystal-structure">4.2 Crystal Structure</h3>
<p>The crystal structure of human ARSB (PDB: 1FSU) provided critical insights into sulfatase catalysis. Key structural features include:</p>
<ul>
<li><strong>Active site:</strong> The catalytic site contains 10 conserved amino acid residues, including the critical Cys91 modified to 3-oxoalanine (formylglycine)</li>
<li><strong>Metal ion:</strong> A calcium ion is coordinated at the active site and is essential for catalysis</li>
<li><strong>Structural homology:</strong> Despite lacking detectable sequence similarity, the ARSB active site domain closely resembles that of alkaline phosphatase. The calcium in ARSB superimposes on one of the zinc ions in alkaline phosphatase, and the oxo-alanine sulfate ester superimposes on the phosphate ion in alkaline phosphatase (Bond et al., 1997)</li>
</ul>
<p>Additional structural studies with vanadate-inhibited ARSB showed that vanadate replaces sulfate at the active site and forms a covalent linkage to the protein, providing insight into the reaction mechanism.</p>
<h3 id="43-post-translational-modifications">4.3 Post-Translational Modifications</h3>
<p>The essential post-translational modification of Cys91 to formylglycine is catalyzed by the formylglycine-generating enzyme (FGE), encoded by the <em>SUMF1</em> gene. This modification:</p>
<ul>
<li>Is absolutely required for catalytic activity</li>
<li>Occurs in the endoplasmic reticulum before ARSB reaches lysosomes</li>
<li>Involves oxidation of the cysteine thiol to an aldehyde in a molecular oxygen-dependent reaction</li>
<li>Requires a conserved sequence motif (CXPXR) surrounding the target cysteine (Dierks et al., 2005)</li>
</ul>
<p>Deficiency of FGE/SUMF1 results in Multiple Sulfatase Deficiency (MSD), where all sulfatases including ARSB show reduced activity.</p>
<hr />
<h2 id="5-disease-associations">5. Disease Associations</h2>
<h3 id="51-mucopolysaccharidosis-type-vi-mps-vi-maroteaux-lamy-syndrome">5.1 Mucopolysaccharidosis Type VI (MPS VI; Maroteaux-Lamy Syndrome)</h3>
<p>ARSB deficiency causes Mucopolysaccharidosis Type VI, an autosomal recessive lysosomal storage disorder first described in 1963. The disease has a prevalence of 0.36-1.3 per 100,000 live births across different populations (Tomatsu et al., 2021).</p>
<p><strong>Genetic heterogeneity:</strong> Over 220 unique <em>ARSB</em> variants have been identified, including:<br />
- Missense variants: 59.5%<br />
- Small deletions: 13.5%<br />
- Nonsense mutations: 12.0%<br />
- Splice site variants: 5.0%</p>
<p>The substantial genetic heterogeneity (with ~32% of variants reported only once) limits genotype-phenotype correlations.</p>
<p><strong>Clinical phenotypes:</strong></p>
<ol>
<li><strong>Rapidly progressing form:</strong></li>
<li>Presents before age 2</li>
<li>Severe skeletal involvement</li>
<li>Adult height typically &lt;120 cm</li>
<li>
<p>Features: claw hands, facial dysmorphism, kyphosis, cardiorespiratory insufficiency</p>
</li>
<li>
<p><strong>Slowly progressing form:</strong></p>
</li>
<li>Normal or mildly coarsened facial features</li>
<li>Delayed diagnosis (average age 23.5 years)</li>
<li>Initial presentation with joint stiffness/pain</li>
</ol>
<p>Notably, MPS VI does not affect cognitive function, distinguishing it from other mucopolysaccharidoses.</p>
<p><strong>Pathophysiology:</strong> The lack of ARSB activity leads to progressive accumulation of dermatan sulfate and chondroitin 4-sulfate in lysosomes, causing:<br />
- Cellular enlargement and organomegaly<br />
- Inflammation and tissue damage<br />
- Secondary disruption of lysosomal function<br />
- Progressive atrophy of affected tissues</p>
<h3 id="52-therapeutic-approaches">5.2 Therapeutic Approaches</h3>
<p><strong>Enzyme Replacement Therapy (ERT):</strong><br />
Galsulfase (Naglazyme), a recombinant human ARSB, was approved by the FDA in 2005. It is administered as weekly intravenous infusions at 1.0 mg/kg. The therapeutic mechanism relies on the M6P receptor-mediated secretion-recapture pathway to deliver exogenous enzyme to cells.</p>
<p>Clinical benefits include:<br />
- Significant reduction in urinary GAG levels<br />
- Improved endurance and joint mobility<br />
- Stabilized cardiac function<br />
- Enhanced survival when initiated before age 5</p>
<p>Limitations include poor efficacy against skeletal manifestations, corneal clouding, and cardiac valve pathology due to poor vascularization of these tissues.</p>
<p><strong>Emerging therapies:</strong><br />
- <strong>Gene therapy:</strong> AAV2/8-mediated <em>ARSB</em> gene transfer shows promise with stable enzyme expression for &gt;1 year<br />
- <strong>Substrate reduction therapy:</strong> Odiparcil reduces GAG synthesis to decrease substrate burden<br />
- <strong>Combination approaches:</strong> Anti-inflammatory agents (infliximab, pentosan polysulfate) combined with ERT</p>
<hr />
<h2 id="6-conclusions">6. Conclusions</h2>
<p>ARSB (Arylsulfatase B) is a well-characterized lysosomal sulfatase that plays an essential role in glycosaminoglycan catabolism. The enzyme specifically removes 4-O-sulfate groups from N-acetylgalactosamine-4-sulfate residues at the non-reducing ends of dermatan sulfate and chondroitin 4-sulfate chains, enabling their sequential degradation. ARSB requires a unique formylglycine post-translational modification for catalytic activity, utilizes a calcium ion at its active site, and is targeted to lysosomes via the mannose-6-phosphate receptor pathway.</p>
<p>Deficiency of ARSB causes Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome), a progressive storage disorder affecting multiple organ systems. The availability of enzyme replacement therapy has improved outcomes for patients, though significant unmet medical need remains, particularly for skeletal and corneal manifestations. Beyond its classical role in lysosomal catabolism, emerging evidence suggests ARSB participates in cellular signaling regulation through control of extracellular GAG sulfation status.</p>
<hr />
<h2 id="references">References</h2>
<ol>
<li>
<p>Bhattacharyya S, et al. (2009). Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. <em>Am J Respir Cell Mol Biol</em>. 42(1):51-61.</p>
</li>
<li>
<p>Bhattacharyya S, et al. (2022). Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases. <em>Int J Mol Sci</em>. 23(21):13146.</p>
</li>
<li>
<p>Bond CS, et al. (1997). Structure of a human lysosomal sulfatase. <em>Structure</em>. 5(2):277-89. [PDB: 1FSU]</p>
</li>
<li>
<p>Braulke T, Bonifacino JS. (2009). Sorting of lysosomal proteins. <em>Biochim Biophys Acta</em>. 1793(4):684-93.</p>
</li>
<li>
<p>Coutinho MF, et al. (2012). Glycosaminoglycan storage disorders: a review. <em>Biochem Res Int</em>. 2012:471325.</p>
</li>
<li>
<p>Dierks T, et al. (2003). Multiple sulfatase deficiency is caused by mutations in the gene encoding the human CŒ±-formylglycine generating enzyme. <em>Cell</em>. 113(4):435-44.</p>
</li>
<li>
<p>Dierks T, et al. (2005). Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme. <em>Cell</em>. 121(4):541-52.</p>
</li>
<li>
<p>Ghosh P, et al. (2003). Mannose 6-phosphate receptors: new twists in the tale. <em>Nat Rev Mol Cell Biol</em>. 4(3):202-12.</p>
</li>
<li>
<p>Hanson SR, et al. (2004). Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. <em>Angew Chem Int Ed</em>. 43(43):5736-63.</p>
</li>
<li>
<p>Monta√±o AM, et al. (2007). Mucopolysaccharidosis IVA: characterization of a common mutation found in British Columbia, Canada. <em>Hum Mutat</em>. 28(6):550.</p>
</li>
<li>
<p>Preusser-Kunze A, et al. (2005). Molecular characterization of the human CŒ±-formylglycine-generating enzyme. <em>J Biol Chem</em>. 280(15):14900-10.</p>
</li>
<li>
<p>Sly WS, et al. (1978). Enzyme replacement in Hunter and Hurler disease: uptake of native enzyme by cultivated fibroblasts. <em>Birth Defects Orig Artic Ser</em>. 14(6B):283-94.</p>
</li>
<li>
<p>Tomatsu S, et al. (2021). Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. <em>Int J Mol Sci</em>. 22(24):13456.</p>
</li>
<li>
<p>Valayannopoulos V, et al. (2010). Mucopolysaccharidosis VI. <em>Orphanet J Rare Dis</em>. 5:5.</p>
</li>
</ol>
<hr />
<h2 id="online-resources-consulted">Online Resources Consulted</h2>
<ul>
<li><a href="https://www.uniprot.org/uniprot/P15848">UniProt P15848</a></li>
<li><a href="https://www.rcsb.org/structure/1FSU">RCSB PDB 1FSU</a></li>
<li><a href="https://omim.org/entry/253200">OMIM 253200 - Mucopolysaccharidosis VI</a></li>
<li><a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARSB">GeneCards ARSB</a></li>
<li><a href="https://medlineplus.gov/genetics/gene/arsb/">MedlinePlus ARSB Gene</a></li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>bhattacharyya_2022_broader_roles.md</li>
<li>bond_1997_structure.md</li>
<li>coutinho_2012_gag_disorders.md</li>
<li>dierks_2003_sumf1.md</li>
<li>tomatsu_2021_mpsvi_review.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ARSB-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15848" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-26T10:22:57.581357'<br />
end_time: '2025-12-26T10:32:10.787115'<br />
duration_seconds: 553.21<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: ARSB<br />
  gene_symbol: ARSB<br />
  uniprot_accession: P15848<br />
  protein_description: 'RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12; AltName:<br />
    Full=N-acetylgalactosamine-4-sulfatase; Short=G4S; Flags: Precursor;'<br />
  gene_info: Name=ARSB;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the sulfatase family. .<br />
  protein_domains: Alkaline_phosphatase_core_sf. (IPR017850); ARSB. (IPR047115); Sulfatase_CS.<br />
    (IPR024607); Sulfatase_N. (IPR000917); Sulfatase (PF00884)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 25</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> P15848</li>
<li><strong>Protein Description:</strong> RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12; AltName: Full=N-acetylgalactosamine-4-sulfatase; Short=G4S; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=ARSB;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the sulfatase family. .</li>
<li><strong>Key Domains:</strong> Alkaline_phosphatase_core_sf. (IPR017850); ARSB. (IPR047115); Sulfatase_CS. (IPR024607); Sulfatase_N. (IPR000917); Sulfatase (PF00884)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ARSB" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ARSB' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ARSB</strong> (gene ID: ARSB, UniProt: P15848) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> P15848</li>
<li><strong>Protein Description:</strong> RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12; AltName: Full=N-acetylgalactosamine-4-sulfatase; Short=G4S; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=ARSB;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the sulfatase family. .</li>
<li><strong>Key Domains:</strong> Alkaline_phosphatase_core_sf. (IPR017850); ARSB. (IPR047115); Sulfatase_CS. (IPR024607); Sulfatase_N. (IPR000917); Sulfatase (PF00884)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ARSB" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ARSB' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ARSB</strong> (gene ID: ARSB, UniProt: P15848) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Comprehensive Research Report: Human ARSB (UniProt P15848)</p>
<p>Executive summary</p>
<ul>
<li>Verified identity: ARSB encodes human arylsulfatase B (N‚Äëacetylgalactosamine‚Äë4‚Äësulfatase), a lysosomal sulfatase (EC 3.1.6.12) that removes the 4‚ÄëO‚Äësulfate from N‚Äëacetylgalactosamine‚Äë4‚Äësulfate residues at the non‚Äëreducing ends of dermatan sulfate and chondroitin‚Äë4‚Äësulfate. Catalysis requires a CŒ±‚Äëformylglycine (FGly) cofactor generated by SUMF1. ARSB is synthesized with a signal peptide, N‚Äëglycosylated, mannose‚Äë6‚Äëphosphate (M6P)‚Äìtagged, and trafficked via the M6P receptor to lysosomes, with reported extra‚Äëlysosomal localization. Deficiency causes mucopolysaccharidosis VI (MPS VI, Maroteaux‚ÄìLamy). (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30, tobacman2022profoundimpactof pages 2-5, stapletonbradley2020screeningandtreatments pages 206-211)</li>
<li>Clinical implementations: Enzyme replacement therapy (ERT) with galsulfase (Naglazyme) is approved for MPS VI, supported by 2024 consensus recommendations and real‚Äëworld pharmacovigilance (2005‚Äì2023 FAERS). Access and multidisciplinary care remain critical system needs. (alsayed2024consensusbasedexpertrecommendations pages 9-11, alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5, li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
</ul>
<p>Key concepts and definitions (current understanding)</p>
<ul>
<li>Molecular identity and family: ARSB is a human lysosomal sulfatase in the broader alkaline phosphatase/sulfatase superfamily; the ARSB gene maps to 5q14.1. The enzyme was historically identified as the ARSB activity deficient in MPS VI. (Tobacman &amp; Bhattacharyya 2022; DOI: https://doi.org/10.3390/ijms232113146) (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30)</li>
<li>Enzymatic reaction and specificity: ARSB catalyzes hydrolysis of the 4‚ÄëO‚Äësulfate at the non‚Äëreducing end of N‚Äëacetylgalactosamine‚Äë4‚Äësulfate, acting on dermatan sulfate and chondroitin‚Äë4‚Äësulfate in glycosaminoglycan (GAG) catabolism; activity is often assayed with nitrocatechol sulfate/4‚Äëmethylumbelliferyl sulfate. (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 2-5)</li>
<li>Catalytic cofactor and activation: The catalytic cysteine (e.g., Cys91) is post‚Äëtranslationally converted to CŒ±‚Äëformylglycine (FGly) by the formylglycine‚Äëgenerating enzyme encoded by SUMF1, a requirement shared across sulfatases and central to the pathobiology of multiple sulfatase deficiency. (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30)</li>
<li>Maturation and targeting: ARSB is synthesized with an N‚Äëterminal signal peptide, undergoes N‚Äëglycosylation and M6P tagging, and is delivered to lysosomes via M6P receptors, where proteolytic maturation yields the active enzyme. Mechanistic background on M6P trafficking and sulfatase maturation is established in the lysosome literature. (Stapleton‚ÄëBradley dissertation 2020; DOI: https://doi.org/10.58088/kwzy-g903) (stapletonbradley2020screeningandtreatments pages 206-211)</li>
<li>Localization: Canonically lysosomal; extra‚Äëlysosomal localization at cell surface and nucleus has been reported in human epithelia and other tissues, suggesting roles beyond classical lysosomal catabolism. (tobacman2022profoundimpactof pages 2-5, tobacman2022profoundimpactof pages 23-25, tobacman2022profoundimpactof pages 30-31)</li>
<li>Disease definition: ARSB deficiency causes MPS VI (Maroteaux‚ÄìLamy), a lysosomal storage disorder with dermatan/chondroitin‚Äë4‚Äësulfate accumulation; SUMF1 defects cause multiple sulfatase deficiency that secondarily impairs ARSB activation. (tobacman2022profoundimpactof pages 16-17, tobacman2022profoundimpactof pages 27-29)</li>
</ul>
<blockquote>
<p>Human ARSB (arylsulfatase B; EC 3.1.6.12) is a member of the sulfatase family that functions as an exo‚Äësulfohydrolase.<br />
It catalyzes hydrolysis of the 4‚ÄëO‚Äësulfate at the non‚Äëreducing terminus of N‚Äëacetylgalactosamine‚Äë4‚Äësulfate residues in dermatan sulfate and chondroitin‚Äë4‚Äësulfate.<br />
Catalysis requires a CŒ±‚Äëformylglycine at the active‚Äësite cysteine, generated post‚Äëtranslationally by the formylglycine‚Äëgenerating enzyme encoded by SUMF1 (FGE).<br />
ARSB is synthesized with an N‚Äëterminal signal peptide, undergoes N‚Äëlinked glycosylation and mannose‚Äë6‚Äëphosphate modification, and is trafficked via M6P receptors to lysosomes where it is proteolytically matured.<br />
While its canonical residence and function are lysosomal in glycosaminoglycan catabolism, extra‚Äëlysosomal localization at the cell surface and in nuclei has been reported.<br />
Loss of ARSB activity causes accumulation of dermatan sulfate and chondroitin‚Äë4‚Äësulfate, producing mucopolysaccharidosis type VI (Maroteaux‚ÄìLamy syndrome), and defective SUMF1 can create a multiple sulfatase deficiency context that impairs ARSB activation.<br />
Because ARSB‚Äëmediated desulfation alters glycosaminoglycan structure, ARSB activity influences extracellular‚Äëmatrix interactions and cell signaling beyond classical lysosomal storage pathology.</p>
</blockquote>
<p><em>Blockquote: Concise, citable summary of ARSB identity, reaction, maturation/trafficking, localization, pathway role, and disease relevance for use in the full report (sources: Tobacman et al. 2022 review and lysosomal trafficking background) (tobacman2022profoundimpactof pages 1-2, stapletonbradley2020screeningandtreatments pages 206-211).</em></p>
<p>Recent developments and latest research (emphasis 2023‚Äì2024)</p>
<ul>
<li>Consensus recommendations for MPS VI (2024): A national Delphi‚Äëstyle expert panel (Saudi Arabia) issued management recommendations for MPS VI, emphasizing immediate initiation of ERT (galsulfase) upon diagnosis, establishment of multidisciplinary care teams, individualized follow‚Äëup, and system‚Äëlevel actions (centers of excellence, national registries, reimbursement programs). Limitations of current ERT (e.g., weekly infusions, limited impact on ocular/skeletal/established cardiac disease) and the need for home‚Äëinfusion pathways are highlighted (Orphanet J Rare Dis, Jul 2024; https://doi.org/10.1186/s13023-024-03237-3). (alsayed2024consensusbasedexpertrecommendations pages 9-11, alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5)</li>
<li>Real‚Äëworld safety of galsulfase (2005‚Äì2023 FAERS, published 2024): A pharmacovigilance analysis of 20,281,876 FAERS reports identified 3,195 galsulfase‚Äëassociated AEs; signal detection across four algorithms found 27 affected organ systems (notably respiratory and infections). Median AE onset was 1,471 days with over half within five years. Newly signaled urologic AEs (e.g., membranous glomerulonephritis, nephritic syndrome) underscore the need for continued surveillance (Frontiers in Pharmacology, Aug 2024; https://doi.org/10.3389/fphar.2024.1420126). (li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
<li>Burden and quality of life (China, 2019 survey; published 2024): In a cross‚Äësectional survey (n=180; includes MPS VI cases) diagnostic delay averaged 9.42 months; only 6.67% were diagnosed at the first visit; patients averaged 6.31 visits and 4.3 hospitals before diagnosis. Direct medical costs during the diagnostic period averaged ¬•81,086.72 (63.75% of total). Only 32.78% had received specific treatments; HRQoL (PedsQL/SF‚Äë36) was significantly lower than population norms, with household income, treatment, and subtype associated with HRQoL (Orphanet J Rare Dis, Sep 2024; https://doi.org/10.1186/s13023-024-03333-4). (kang2024healthserviceutilization pages 1-2, kang2024healthserviceutilization pages 6-8)</li>
<li>Mechanistic breadth (2022‚Äì2024): Reviews and preclinical reports continue to detail ARSB‚Äôs regulation of cell‚Äësignaling via changes in chondroitin‚Äë4‚Äësulfate sulfation and binding partners, plus extra‚Äëlysosomal localizations in human tissues; these support expanding biological roles beyond classical storage pathology. (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 23-25, tobacman2022profoundimpactof pages 30-31)</li>
</ul>
<p>Current applications and real‚Äëworld implementations</p>
<ul>
<li>Enzyme replacement therapy (ERT): Galsulfase is the approved recombinant human ARSB for MPS VI. Clinical consensus emphasizes early initiation and structured, multidisciplinary follow‚Äëup, with selective use of home‚Äëinfusion programs to improve adherence and access (Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03237-3). (alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5)</li>
<li>Pharmacovigilance in practice: FAERS data through Q4 2023 provide real‚Äëworld AE profiles and onset timing for galsulfase‚Äîsupporting risk communication, monitoring plans, and hypothesis generation for rare, off‚Äëlabel, or long‚Äëlatency events (Frontiers in Pharmacology 2024; https://doi.org/10.3389/fphar.2024.1420126). (li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
<li>Health systems and access: National‚Äëlevel recommendations and burden studies identify the need for centers of excellence, registries, and reimbursement mechanisms to reduce diagnostic delay and improve equitable ERT access. China‚Äôs national rare‚Äëdisease network (since 2019) illustrates system‚Äëlevel responses to these needs (Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03333-4; Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03237-3). (kang2024healthserviceutilization pages 1-2, kang2024healthserviceutilization pages 6-8, alsayed2024consensusbasedexpertrecommendations pages 9-11)</li>
</ul>
<p>Expert opinions and authoritative analysis</p>
<ul>
<li>National expert consensus: The 2024 Saudi consensus provides structured recommendations for MPS VI care delivery, including early ERT, multidisciplinary management, and system‚Äëlevel reforms, reflecting authoritative, context‚Äëadapted clinical guidance (Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03237-3). (alsayed2024consensusbasedexpertrecommendations pages 9-11, alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5)</li>
<li>Mechanistic reviews: ARSB‚Äôs core biochemistry, SUMF1‚Äëdependent activation, and expanding physiological roles are reviewed with synthesis across human and model data, supporting the canonical lysosomal catabolic function and extra‚Äëlysosomal activities (IJMS 2022; https://doi.org/10.3390/ijms232113146). (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30, tobacman2022profoundimpactof pages 2-5)</li>
</ul>
<p>Relevant statistics and data (recent studies)</p>
<ul>
<li>Galsulfase AE profile (FAERS 2005‚Äì2023): 3,195 galsulfase‚Äëassociated AE reports; 27 organ systems implicated; median AE onset 1,471 days; over half within five years; new urologic signals observed‚Äîpublication Aug 2024 (Frontiers in Pharmacology; https://doi.org/10.3389/fphar.2024.1420126). (li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
<li>Diagnostic journey and costs (China, published 2024): Mean diagnostic delay 9.42 months; 6.67% diagnosed at first visit; average 6.31 visits/4.3 hospitals before diagnosis; mean direct medical costs during diagnosis ¬•81,086.72 (63.75% of total); only 32.78% received specific treatments; HRQoL significantly below norms (Orphanet J Rare Dis; https://doi.org/10.1186/s13023-024-03333-4). (kang2024healthserviceutilization pages 1-2, kang2024healthserviceutilization pages 6-8)</li>
</ul>
<p>Detailed functional annotation of ARSB</p>
<ul>
<li>Reaction and pathway: ARSB is an exo‚Äësulfohydrolase that removes terminal 4‚ÄëO‚Äësulfate from GalNAc‚Äë4‚Äësulfate residues in dermatan sulfate/chondroitin‚Äë4‚Äësulfate, a late step in lysosomal GAG breakdown. Deficiency elevates C4S/DS storage, driving MPS VI pathology in cartilage, connective tissues, and viscera. (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 2-5, tobacman2022profoundimpactof pages 16-17)</li>
<li>Subcellular localization: Predominantly lysosomal via M6P‚Äëguided trafficking; extra‚Äëlysosomal localizations (cell surface, nucleus) have been reported in human epithelium, liver, and other tissues, suggesting signaling effects through altered GAG sulfation in microdomains. (tobacman2022profoundimpactof pages 2-5, tobacman2022profoundimpactof pages 23-25, tobacman2022profoundimpactof pages 30-31)</li>
<li>Maturation and cofactor biology: SUMF1‚Äëdependent FGly generation is essential for catalysis; defects in SUMF1 produce multiple sulfatase deficiency with broad loss of sulfatase activities including ARSB. M6P receptor‚Äìmediated sorting and proteolytic maturation complete activation and lysosomal deployment. (tobacman2022profoundimpactof pages 29-30, stapletonbradley2020screeningandtreatments pages 206-211)</li>
</ul>
<p>Clinical relevance and therapy landscape</p>
<ul>
<li>MPS VI (Maroteaux‚ÄìLamy): ARSB mutations cause MPS VI; disease burden includes progressive skeletal dysplasia, cardiopulmonary disease, ophthalmic involvement, and systemic manifestations. ERT with galsulfase improves endurance, pulmonary function, and global symptoms, though limitations exist for skeletal/ocular/established cardiac disease. Early initiation and coordinated multidisciplinary care are advised. (Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03237-3) (alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5)</li>
<li>Safety and monitoring: Long‚Äëterm pharmacovigilance indicates multi‚Äësystem AEs and emerging signals, reinforcing the need for structured monitoring programs and registry‚Äëbased follow‚Äëup (Frontiers in Pharmacology 2024; https://doi.org/10.3389/fphar.2024.1420126). (li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
<li>Health systems perspective: Real‚Äëworld data emphasize substantial diagnostic delays, financial burden, and under‚Äëutilization of specific therapies, motivating national networks, reimbursement schemes, and home‚Äëinfusion options to improve outcomes and equity (Orphanet J Rare Dis 2024; https://doi.org/10.1186/s13023-024-03333-4; https://doi.org/10.1186/s13023-024-03237-3). (kang2024healthserviceutilization pages 1-2, kang2024healthserviceutilization pages 6-8, alsayed2024consensusbasedexpertrecommendations pages 9-11)</li>
</ul>
<p>Verification of gene/protein identity and ambiguity check</p>
<ul>
<li>The ARSB symbol corresponds to human arylsulfatase B (N‚Äëacetylgalactosamine‚Äë4‚Äësulfatase; UniProt P15848), a lysosomal sulfatase. Literature cited above consistently studies human ARSB and the human disease MPS VI; no conflicting use of the symbol for a different gene/protein in another organism was found in the evidence set used here. Domain/family assignment (sulfatase) and required FGly modification align with sulfatase family characteristics. (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30, tobacman2022profoundimpactof pages 2-5)</li>
</ul>
<p>References and source metadata</p>
<ul>
<li>Tobacman JK, Bhattacharyya S. Profound impact of decline in N‚Äëacetylgalactosamine‚Äë4‚Äësulfatase (Arylsulfatase B) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences. Published Oct 2022. URL: https://doi.org/10.3390/ijms232113146 (tobacman2022profoundimpactof pages 1-2, tobacman2022profoundimpactof pages 29-30, tobacman2022profoundimpactof pages 23-25, tobacman2022profoundimpactof pages 30-31, tobacman2022profoundimpactof pages 16-17, tobacman2022profoundimpactof pages 27-29, tobacman2022profoundimpactof pages 2-5)</li>
<li>AlSayed M, et al. Consensus‚Äëbased expert recommendations on the management of MPS IVa and VI in Saudi Arabia. Orphanet Journal of Rare Diseases. Published Jul 2024. URL: https://doi.org/10.1186/s13023-024-03237-3 (alsayed2024consensusbasedexpertrecommendations pages 9-11, alsayed2024consensusbasedexpertrecommendations pages 2-4, alsayed2024consensusbasedexpertrecommendations pages 4-5)</li>
<li>Li S, et al. Real‚Äëworld pharmacovigilance analysis of galsulfase (FAERS 2005‚Äì2023). Frontiers in Pharmacology. Published Aug 2024. URL: https://doi.org/10.3389/fphar.2024.1420126 (li2024realworldpharmacovigilanceanalysis pages 1-2)</li>
<li>Kang Q, et al. Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China. Orphanet Journal of Rare Diseases. Published Sep 2024. URL: https://doi.org/10.1186/s13023-024-03333-4 (kang2024healthserviceutilization pages 6-8, kang2024healthserviceutilization pages 1-2)</li>
<li>Stapleton‚ÄëBradley M. Screening and treatments for the mucopolysaccharidoses (dissertation). University of Delaware. Published 2020. URL: https://doi.org/10.58088/kwzy-g903 (stapletonbradley2020screeningandtreatments pages 206-211)</li>
</ul>
<p>Limitations</p>
<ul>
<li>Some mechanistic background on lysosomal targeting and M6P trafficking is derived from established literature summarized in a dissertation source in the evidence set; readers should refer to primary lysosome/M6P receptor reviews for additional mechanistic detail. (stapletonbradley2020screeningandtreatments pages 206-211)</li>
</ul>
<p>References</p>
<ol>
<li>
<p>(tobacman2022profoundimpactof pages 1-2): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 29-30): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 2-5): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(stapletonbradley2020screeningandtreatments pages 206-211): Molly Stapleton-Bradley. Screening and treatments for the mucopolysaccharidoses. Dissertation, 2020. URL: https://doi.org/10.58088/kwzy-g903, doi:10.58088/kwzy-g903. This article has 0 citations.</p>
</li>
<li>
<p>(alsayed2024consensusbasedexpertrecommendations pages 9-11): Moeenaldeen AlSayed, Dia Arafa, Huda Al-Khawajha, Manal Afqi, Nouriya Al-Sanna‚Äôa, Rawda Sunbul, and Maha Faden. Consensus-based expert recommendations on the management of mps iva and vi in saudi arabia. Orphanet Journal of Rare Diseases, Jul 2024. URL: https://doi.org/10.1186/s13023-024-03237-3, doi:10.1186/s13023-024-03237-3. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(alsayed2024consensusbasedexpertrecommendations pages 2-4): Moeenaldeen AlSayed, Dia Arafa, Huda Al-Khawajha, Manal Afqi, Nouriya Al-Sanna‚Äôa, Rawda Sunbul, and Maha Faden. Consensus-based expert recommendations on the management of mps iva and vi in saudi arabia. Orphanet Journal of Rare Diseases, Jul 2024. URL: https://doi.org/10.1186/s13023-024-03237-3, doi:10.1186/s13023-024-03237-3. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(alsayed2024consensusbasedexpertrecommendations pages 4-5): Moeenaldeen AlSayed, Dia Arafa, Huda Al-Khawajha, Manal Afqi, Nouriya Al-Sanna‚Äôa, Rawda Sunbul, and Maha Faden. Consensus-based expert recommendations on the management of mps iva and vi in saudi arabia. Orphanet Journal of Rare Diseases, Jul 2024. URL: https://doi.org/10.1186/s13023-024-03237-3, doi:10.1186/s13023-024-03237-3. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(li2024realworldpharmacovigilanceanalysis pages 1-2): Shangze Li, Runcheng Huang, Yuanyuan Meng, Yijia Liu, Jiao Qian, Junjie Zou, and Jun Yang. Real-world pharmacovigilance analysis of galsulfase: a study based on the fda adverse event reporting system (faers) database. Frontiers in Pharmacology, Aug 2024. URL: https://doi.org/10.3389/fphar.2024.1420126, doi:10.3389/fphar.2024.1420126. This article has 2 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 23-25): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 30-31): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 16-17): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tobacman2022profoundimpactof pages 27-29): Joanne K Tobacman and Sumit Bhattacharyya. Profound impact of decline in n-acetylgalactosamine-4-sulfatase (arylsulfatase b) on molecular pathophysiology and human diseases. International Journal of Molecular Sciences, Oct 2022. URL: https://doi.org/10.3390/ijms232113146, doi:10.3390/ijms232113146. This article has 23 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(kang2024healthserviceutilization pages 1-2): Qi Kang, Yuhang Fang, Yan Yang, Dingguo Li, Lin Zheng, Xinyi Chen, Xiaowen Tu, and Chunlin Jin. Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in china. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03333-4, doi:10.1186/s13023-024-03333-4. This article has 9 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(kang2024healthserviceutilization pages 6-8): Qi Kang, Yuhang Fang, Yan Yang, Dingguo Li, Lin Zheng, Xinyi Chen, Xiaowen Tu, and Chunlin Jin. Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in china. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03333-4, doi:10.1186/s13023-024-03333-4. This article has 9 citations and is from a peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>stapletonbradley2020screeningandtreatments pages 206-211</li>
<li>li2024realworldpharmacovigilanceanalysis pages 1-2</li>
<li>tobacman2022profoundimpactof pages 1-2</li>
<li>tobacman2022profoundimpactof pages 29-30</li>
<li>tobacman2022profoundimpactof pages 2-5</li>
<li>alsayed2024consensusbasedexpertrecommendations pages 9-11</li>
<li>alsayed2024consensusbasedexpertrecommendations pages 2-4</li>
<li>alsayed2024consensusbasedexpertrecommendations pages 4-5</li>
<li>tobacman2022profoundimpactof pages 23-25</li>
<li>tobacman2022profoundimpactof pages 30-31</li>
<li>tobacman2022profoundimpactof pages 16-17</li>
<li>tobacman2022profoundimpactof pages 27-29</li>
<li>kang2024healthserviceutilization pages 1-2</li>
<li>kang2024healthserviceutilization pages 6-8</li>
<li>https://doi.org/10.3390/ijms232113146</li>
<li>https://doi.org/10.58088/kwzy-g903</li>
<li>https://doi.org/10.1186/s13023-024-03237-3</li>
<li>https://doi.org/10.3389/fphar.2024.1420126</li>
<li>https://doi.org/10.1186/s13023-024-03333-4</li>
<li>https://doi.org/10.1186/s13023-024-03333-4;</li>
<li>https://doi.org/10.3390/ijms232113146,</li>
<li>https://doi.org/10.58088/kwzy-g903,</li>
<li>https://doi.org/10.1186/s13023-024-03237-3,</li>
<li>https://doi.org/10.3389/fphar.2024.1420126,</li>
<li>https://doi.org/10.1186/s13023-024-03333-4,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity Lite</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ARSB-deep-research-perplexity-lite.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15848" data-a="DOC: Deep Research Perplexity Lite" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-pro<br />
cached: false<br />
start_time: '2025-11-15T18:18:29.512838'<br />
end_time: '2025-11-15T18:18:49.160449'<br />
duration_seconds: 19.65<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: low<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 9</p>
<hr />
<h2 id="question">Question</h2>
<p>Research the ARSB (ARSB) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.</p>
<h2 id="output">Output</h2>
<p>The <strong>ARSB (arylsulfatase B)</strong> gene encodes a lysosomal enzyme essential for the degradation of specific glycosaminoglycans (GAGs), with broad implications for cellular metabolism, signaling, and human disease[1][2][3][6][8].</p>
<hr />
<p><strong>Key Concepts and Definitions</strong></p>
<ul>
<li>
<p><strong>Molecular Function:</strong><br />
  ARSB encodes the enzyme <strong>N-acetylgalactosamine-4-sulfatase</strong>, which hydrolyzes (removes) 4-sulfate groups from the GAGs <strong>dermatan sulfate</strong> and <strong>chondroitin-4-sulfate</strong>[1][2][3][6][8]. This activity is classified as <strong>sulfuric ester hydrolase activity</strong> and is critical for the stepwise degradation of these GAGs in lysosomes[3][6][8].</p>
</li>
<li>
<p><strong>Biological Processes:</strong>  </p>
</li>
<li><strong>Lysosomal degradation of GAGs:</strong> ARSB is central to the catabolism of dermatan sulfate and chondroitin sulfate, preventing their accumulation[1][2][3][6][8].</li>
<li><strong>Extracellular matrix remodeling:</strong> ARSB influences the composition and turnover of the extracellular matrix, affecting cell adhesion, migration, and invasion[1][3][8].</li>
<li><strong>Cell signaling:</strong> ARSB modulates signaling pathways, including those involving inflammatory mediators (e.g., interleukin-8), and impacts RhoA activation and matrix metalloproteinase secretion[1].</li>
<li>
<p><strong>Neuronal development:</strong> In the central nervous system, ARSB regulates neurite outgrowth and neuronal plasticity by controlling sulfate GAG and neurocan levels[3][6][8].</p>
</li>
<li>
<p><strong>Cellular Localization:</strong>  </p>
</li>
<li><strong>Primary:</strong> ARSB is predominantly a <strong>lysosomal enzyme</strong>[1][2][3][4][6][8].</li>
<li><strong>Extra-lysosomal:</strong> Immunohistochemistry and immunofluorescence studies have also detected ARSB at the <strong>cell membrane</strong> of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells[4]. Membrane localization is reduced in malignant tissues[4].</li>
</ul>
<hr />
<p><strong>Protein Domains and Structure</strong></p>
<ul>
<li><strong>Protein Family:</strong> ARSB belongs to the <strong>sulfatase family</strong>[1][3][6][8].</li>
<li><strong>Domain Structure:</strong>  </li>
<li>The enzyme is a <strong>homodimer</strong>[1][3].</li>
<li>Contains a <strong>sulfatase domain</strong> responsible for its catalytic activity[8].</li>
<li>The active site includes a <strong>formylglycine</strong> residue, essential for catalysis, generated by post-translational modification[6][8].</li>
<li><strong>Isoforms:</strong> Two alternatively spliced transcript variants encoding distinct isoforms have been identified[1][3].</li>
</ul>
<hr />
<p><strong>Known Interactions</strong></p>
<ul>
<li><strong>Protein-Protein Interactions:</strong>  </li>
<li>ARSB interacts with <strong>galectin-3</strong>, influencing the expression of the proteoglycan <strong>versican</strong> via AP-1-mediated transcription[5].</li>
<li>Reduced ARSB activity increases galectin-3 binding to less-sulfated chondroitin-4-sulfate, affecting transcription factors (AP-1, SP-1) and downstream targets (e.g., WNT9A, GPNMB)[4][5].</li>
<li>ARSB deficiency leads to increased binding of <strong>SHP2</strong> to more-sulfated chondroitin-4-sulfate, activating signaling pathways (p38, MITF)[4].</li>
<li><strong>Pathway Involvement:</strong>  </li>
<li>ARSB is involved in <strong>glycosaminoglycan metabolism</strong> and <strong>sphingolipid metabolism</strong>[3].</li>
</ul>
<hr />
<p><strong>Disease Associations</strong></p>
<ul>
<li><strong>Mucopolysaccharidosis Type VI (MPS VI, Maroteaux‚ÄìLamy syndrome):</strong>  </li>
<li><strong>Cause:</strong> Autosomal recessive deficiency of ARSB leads to lysosomal accumulation of dermatan sulfate and chondroitin sulfate[1][2][3][4][6].</li>
<li><strong>Clinical Features:</strong> Multi-system involvement, including skeletal, cardiac, and ocular abnormalities, organomegaly, and progressive tissue damage[1][2][3].</li>
<li><strong>Cancer:</strong>  </li>
<li>Reduced ARSB expression is linked to altered proteoglycan expression and tumor progression in prostate and colonic epithelial cells[1][4].</li>
<li>Acts as a <strong>tumor suppressor</strong>; silencing ARSB increases galectin-3 and promotes oncogenic signaling[4].</li>
<li><strong>Cystic Fibrosis:</strong>  </li>
<li>ARSB activity is modulated by the cystic fibrosis transmembrane conductance regulator (CFTR), with implications for disease pathology[4].</li>
<li><strong>Atherosclerosis-related Stroke:</strong>  </li>
<li>Emerging evidence suggests a role for ARSB in promoting atherosclerosis-related stroke, warranting further investigation[7].</li>
<li><strong>Metachromatic Leukodystrophy:</strong>  </li>
<li>ARSB is also associated with this lysosomal storage disorder, though less commonly than MPS VI[3].</li>
</ul>
<hr />
<p><strong>Recent Developments and Research (2023‚Äì2024)</strong></p>
<ul>
<li><strong>Therapeutic Approaches:</strong>  </li>
<li>Enzyme replacement therapy (ERT) with recombinant ARSB is the standard treatment for MPS VI, aiming to reduce GAG accumulation and ameliorate symptoms[1].</li>
<li>Research is ongoing into gene therapy and small-molecule approaches to enhance ARSB activity or delivery, including targeting extra-lysosomal pools for tissue-specific effects[1].</li>
<li><strong>Cancer and Metabolism:</strong>  </li>
<li>Recent studies highlight ARSB‚Äôs role in tumor suppression and metabolic regulation, including effects on aerobic glycolysis and mitochondrial function in cancer cells[4].</li>
<li><strong>Tissue Engineering:</strong>  </li>
<li>ARSB is being explored for its potential to modify extracellular matrix composition and support tissue recovery after injury[1].</li>
</ul>
<hr />
<p><strong>Relevant Statistics and Data</strong></p>
<ul>
<li><strong>Functional Associations:</strong>  </li>
<li>ARSB has over <strong>6,400 functional associations</strong> with biological entities across molecular, cellular, and disease categories, as extracted from 106 datasets[1].</li>
<li><strong>Expression:</strong>  </li>
<li>ARSB is expressed in multiple tissues, with highest levels in the <strong>liver, pancreas, and kidneys</strong>[4].</li>
</ul>
<hr />
<p><strong>Expert Opinions and Analysis</strong></p>
<ul>
<li><strong>Central Role in Lysosomal Homeostasis:</strong>  </li>
<li>Experts emphasize ARSB‚Äôs indispensable function in lysosomal GAG degradation and its broader impact on cell signaling and tissue architecture[1][2][3][6][8].</li>
<li><strong>Therapeutic Target:</strong>  </li>
<li>ARSB is a validated target for enzyme replacement in MPS VI and is under investigation for broader applications in cancer and tissue engineering[1][4].</li>
</ul>
<hr />
<p><strong>Citations (with URLs and Dates where available):</strong></p>
<ul>
<li><a href="https://maayanlab.cloud/Harmonizome/gene/ARSB">Ma‚Äôayan Lab Harmonizome, ARSB gene</a> (2024)</li>
<li><a href="https://medlineplus.gov/genetics/gene/arsb/">MedlinePlus Genetics, ARSB gene</a> (2024)</li>
<li><a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARSB">GeneCards, ARSB</a> (2024)</li>
<li><a href="https://en.wikipedia.org/wiki/Arylsulfatase_B">Wikipedia, Arylsulfatase B</a> (2024)</li>
<li><a href="https://www.ncbi.nlm.nih.gov/gene/411">NCBI Gene, ARSB</a> (2024)</li>
<li><a href="https://www.uniprot.org/uniprotkb/P15848/entry">UniProt, ARSB_HUMAN (P15848)</a> (2024)</li>
<li><a href="https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=411">NCBI Gene, ARSB</a> (2024)</li>
<li><a href="https://www.ebi.ac.uk/interpro/protein/reviewed/P15848">InterPro, Arylsulfatase B (P15848)</a> (2024)</li>
<li><a href="https://www.proteinatlas.org/ENSG00000113273-ARSB/structure+interaction">Human Protein Atlas, ARSB</a> (2024)</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>https://maayanlab.cloud/Harmonizome/gene/ARSB</li>
<li>https://medlineplus.gov/genetics/gene/arsb/</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARSB</li>
<li>https://en.wikipedia.org/wiki/Arylsulfatase_B</li>
<li>https://www.ncbi.nlm.nih.gov/gene/411</li>
<li>https://www.uniprot.org/uniprotkb/P15848/entry</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=411</li>
<li>https://www.ebi.ac.uk/interpro/protein/reviewed/P15848</li>
<li>https://www.proteinatlas.org/ENSG00000113273-ARSB/structure+interaction</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: P15848
gene_symbol: ARSB
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: Arylsulfatase B (ARSB) is a lysosomal enzyme that catalyzes the hydrolysis of 4-sulfate groups
  from N-acetylgalactosamine residues within chondroitin-4-sulfate and dermatan sulfate. This sulfatase
  activity is essential for the ordered degradation of glycosaminoglycans in lysosomes. Deficiency of
  ARSB leads to mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome), characterized by accumulation
  of dermatan sulfate and chondroitin sulfate. Beyond its lysosomal role, ARSB regulates extracellular
  matrix composition, cell migration, and signaling pathways by controlling sulfation patterns of glycosaminoglycans.
existing_annotations:
- term:
    id: GO:0008484
    label: sulfuric ester hydrolase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: This IBA annotation correctly identifies ARSB as a sulfuric ester hydrolase, which is accurate
      as ARSB catalyzes hydrolysis of sulfate ester bonds. This is the broader enzymatic class encompassing
      the more specific N-acetylgalactosamine-4-sulfatase activity. The phylogenetic evidence supporting
      this annotation is strong across mammalian orthologs.
    action: ACCEPT
    reason: This is an appropriate molecular function term that accurately reflects the core catalytic
      activity of ARSB. While more general than the specific N-acetylgalactosamine-4-sulfatase activity,
      it correctly places ARSB in the sulfatase family. The IBA evidence based on phylogenetic conservation
      is robust.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid
        sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial
        degree of similarity suggesting that they arose from a common ancestral gene and are members of
        an arylsulfatase gene family.
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12&#39;
    - reference_id: file:human/ARSB/ARSB-deep-research-falcon.md
      supporting_text: See deep research file for comprehensive analysis
- term:
    id: GO:0003943
    label: N-acetylgalactosamine-4-sulfatase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000003
  review:
    summary: This annotation correctly identifies the specific enzymatic activity of ARSB. The EC mapping
      (EC:3.1.6.12) accurately reflects that ARSB catalyzes the hydrolysis of 4-sulfate groups from N-acetylgalactosamine
      residues in both chondroitin sulfate and dermatan sulfate. This is the primary and most specific
      molecular function of ARSB.
    action: ACCEPT
    reason: This is the most precise molecular function term for ARSB and should be retained as a core
      annotation. Although this is IEA based on EC mapping, it is also supported by multiple experimental
      studies (IDA annotations from PMID:18285341 and PMID:19306108).
    supported_by:
    - reference_id: PMID:18285341
      supporting_text: The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB))
        and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS.
    - reference_id: PMID:19306108
      supporting_text: Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is
        the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines
        with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S).
    - reference_id: Reactome:R-HSA-1793207
      supporting_text: Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine
        4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate
- term:
    id: GO:0004065
    label: arylsulfatase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: This annotation identifies ARSB as having arylsulfatase activity, which is a broader classification
      than the specific N-acetylgalactosamine-4-sulfatase activity. While technically correct, this term
      is somewhat less informative than GO:0003943.
    action: ACCEPT
    reason: This annotation is correct and reflects the arylsulfatase family membership of ARSB. Although
      broader than the specific sulfatase activity, it is appropriate to retain this alongside the more
      specific term, as it reflects the historical nomenclature and biochemical classification. This is
      also supported by a TAS annotation.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human
        arylsulfatase B. [...] members of an arylsulfatase gene family.
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;RecName: Full=Arylsulfatase B&#39;
- term:
    id: GO:0005764
    label: lysosome
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: This annotation correctly places ARSB in the lysosome, which is the primary and well-established
      cellular compartment where ARSB functions. ARSB is a classical lysosomal enzyme that degrades glycosaminoglycans
      in this organelle.
    action: ACCEPT
    reason: This is a core cellular component annotation for ARSB. The lysosomal localization is extensively
      documented and is the primary site of ARSB function in glycosaminoglycan degradation. This is supported
      by both IEA and TAS evidence, as well as the original biochemical characterization of the enzyme.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes
        was accomplished in a mannose 6-phosphate receptor-dependent manner.
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;SUBCELLULAR LOCATION: Lysosome&#39;
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: &#39;Primary: ARSB is predominantly a lysosomal enzyme&#39;
- term:
    id: GO:0008484
    label: sulfuric ester hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This is a duplicate annotation of the IBA sulfuric ester hydrolase activity annotation (line
      2 of GOA file), but with different evidence (IEA from combined automated methods) and ortholog mapping
      to rat ARSB.
    action: ACCEPT
    reason: While this is a duplicate GO term, it represents independent evidence from automated orthology
      mapping, which reinforces the IBA annotation. It is acceptable to have the same term with different
      evidence codes.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid
        sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial
        degree of similarity
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This annotation indicates ARSB localizes to the cell surface. While ARSB is primarily lysosomal,
      there is evidence from UniProt and literature that ARSB can be detected at the cell membrane in
      certain cell types, particularly in colonic and prostatic epithelial cells. This extra-lysosomal
      localization may have functional significance.
    action: ACCEPT
    reason: Although ARSB is predominantly a lysosomal enzyme, the evidence for cell surface localization
      should not be dismissed. The deep research document notes that ARSB has been detected at cell membranes,
      and this may represent a non-core but biologically relevant localization. There is also an ISS annotation
      supporting this.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: &#39;Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also
        detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells,
        and the apical membranes of colonic and prostatic epithelial cells. Membrane localization is reduced
        in malignant tissues.&#39;
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;SUBCELLULAR LOCATION: Lysosome. Cell surface.&#39;
- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This is a very broad molecular function term indicating that ARSB is a hydrolase, which is
      technically correct but not informative. This term is the parent of more specific terms like sulfuric
      ester hydrolase activity.
    action: ACCEPT
    reason: While this term is extremely broad and not very informative, it is technically correct and
      represents the top-level enzymatic classification. It is acceptable to keep this alongside more
      specific terms, as it may be useful for broad queries. However, this is clearly less informative
      than the more specific sulfatase activity terms.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: EC=3.1.6.12 [hydrolase class]
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This annotation indicates metal ion binding activity. ARSB requires calcium as a cofactor,
      binding one Ca2+ ion per subunit. The term is somewhat generic but is biochemically accurate.
    action: MODIFY
    reason: While ARSB does bind metal ions, specifically calcium, the current term is too generic. A
      more specific term would be calcium ion binding (GO:0005509), which accurately reflects the specific
      metal requirement documented in UniProt and Reactome. The current term should be replaced with the
      more specific calcium ion binding term.
    proposed_replacement_terms:
    - id: GO:0005509
      label: calcium ion binding
    supported_by:
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit.&#39;
    - reference_id: Reactome:R-HSA-1793207
      supporting_text: Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine
        4-sulfate
- term:
    id: GO:0006914
    label: autophagy
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation suggests ARSB is involved in autophagy, based on orthology to rat ARSB. While
      ARSB is a lysosomal enzyme and lysosomes are involved in autophagy, there is no direct evidence
      that ARSB specifically participates in autophagic processes beyond being a general lysosomal enzyme.
    action: REMOVE
    reason: This annotation appears to be an over-annotation. While ARSB is lysosomal and lysosomes participate
      in autophagy, there is no specific evidence that ARSB has a direct functional role in autophagy
      itself. ARSB&#39;s primary function is glycosaminoglycan degradation, not autophagy regulation. This
      annotation likely arises from guilt-by-association with the lysosome rather than a specific biological
      role.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: ARSB encodes the enzyme N-acetylgalactosamine-4-sulfatase, which hydrolyzes (removes)
        4-sulfate groups from the GAGs dermatan sulfate and chondroitin-4-sulfate [does not mention autophagy
        as a specific function]
- term:
    id: GO:0007584
    label: response to nutrient
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation suggests ARSB is involved in response to nutrient, based on orthology to
      rat. There is no specific evidence that ARSB responds to or regulates nutrient sensing beyond its
      general role as a lysosomal enzyme.
    action: REMOVE
    reason: This appears to be an over-annotation without specific supporting evidence. While lysosomal
      function can be influenced by nutrient status, there is no indication that ARSB specifically mediates
      nutrient response pathways. This annotation likely reflects general lysosomal biology rather than
      a specific ARSB function.
    supported_by: []
- term:
    id: GO:0009268
    label: response to pH
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation indicates ARSB is involved in response to pH. As a lysosomal enzyme, ARSB
      functions optimally at acidic pH (the lysosomal environment), but there is no evidence it specifically
      responds to or regulates pH.
    action: REMOVE
    reason: This is an over-annotation. While ARSB activity is pH-dependent (like most lysosomal enzymes
      that function optimally at acidic pH), this does not mean ARSB is involved in pH response as a biological
      process. The term implies ARSB actively participates in sensing or responding to pH changes, which
      is not supported by evidence.
    supported_by: []
- term:
    id: GO:0010976
    label: positive regulation of neuron projection development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation suggests ARSB positively regulates neuron projection development, based on
      orthology to rat. UniProt states that in the central nervous system, ARSB is a regulator of neurite
      outgrowth and neuronal plasticity through control of sulfate glycosaminoglycans and neurocan levels,
      though this is based on similarity evidence.
    action: KEEP_AS_NON_CORE
    reason: While there is supporting evidence from UniProt (based on similarity) that ARSB regulates
      neurite outgrowth in the CNS, this appears to be a non-core, tissue-specific function rather than
      a primary function of ARSB. The core function is glycosaminoglycan degradation; the neuronal effects
      are downstream consequences of this activity in neural tissue. This should be retained but marked
      as non-core.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: In the central nervous system, is a regulator of neurite outgrowth and neuronal
        plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity).
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: &#39;Neuronal development: In the central nervous system, ARSB regulates neurite outgrowth
        and neuronal plasticity by controlling sulfate GAG and neurocan levels&#39;
- term:
    id: GO:0043627
    label: response to estrogen
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation suggests ARSB is involved in response to estrogen, based on orthology to
      rat. There is no specific evidence in the literature or UniProt that ARSB directly responds to or
      mediates estrogen signaling.
    action: REMOVE
    reason: This appears to be an over-annotation without supporting evidence. While ARSB expression levels
      might be influenced by various factors including hormones, there is no specific evidence that ARSB
      plays a role in estrogen response pathways. This annotation should be removed unless specific evidence
      emerges.
    supported_by: []
- term:
    id: GO:0051597
    label: response to methylmercury
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation suggests ARSB is involved in response to methylmercury, based on orthology
      to rat. This appears to be an artifact of expression studies in rats and does not reflect a specific
      biological function of ARSB.
    action: REMOVE
    reason: This is an over-annotation that likely reflects experimental conditions in rat studies rather
      than a genuine biological function. There is no evidence that ARSB has a specific role in methylmercury
      response or detoxification. This should be removed.
    supported_by: []
- term:
    id: GO:0003943
    label: N-acetylgalactosamine-4-sulfatase activity
  evidence_type: IDA
  original_reference_id: PMID:18285341
  review:
    summary: This is experimental (IDA) confirmation of the specific N-acetylgalactosamine-4-sulfatase
      activity of ARSB. The study directly demonstrated that ARSB hydrolyzes sulfate groups from chondroitin
      sulfates and that modifying ARSB expression affects chondroitin-4-sulfate levels.
    action: ACCEPT
    reason: This is a gold-standard experimental annotation that directly demonstrates the primary molecular
      function of ARSB. This is core evidence supporting the specific enzymatic activity and should definitely
      be retained.
    supported_by:
    - reference_id: PMID:18285341
      supporting_text: The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB))
        and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS. [...] Following silencing of
        ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB
        or GALNS, total sGAG, C4S, and CS declined significantly.
- term:
    id: GO:0030207
    label: chondroitin sulfate proteoglycan catabolic process
  evidence_type: IDA
  original_reference_id: PMID:18285341
  review:
    summary: This experimental annotation indicates ARSB is involved in chondroitin sulfate proteoglycan
      catabolism. The study demonstrated that ARSB expression affects the content of chondroitin sulfate
      and its proteoglycans, with overexpression leading to reduced CS and increased syndecan-1 and decorin
      core protein expression.
    action: ACCEPT
    reason: This annotation is well-supported by experimental evidence. The study shows that ARSB affects
      both the glycosaminoglycan chains and the proteoglycan content, justifying annotation to the proteoglycan
      catabolic process. ARSB&#39;s enzymatic removal of sulfate groups from chondroitin sulfate chains is
      a key step in proteoglycan degradation.
    supported_by:
    - reference_id: PMID:18285341
      supporting_text: Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly.
        Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly.
    - reference_id: PMID:18285341
      supporting_text: mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1
        and decorin, was significantly up-regulated following overexpression of ASB
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2282889
  review:
    summary: This annotation places ARSB in the lysosomal lumen based on Reactome pathway annotation for
      defective ARSB in MPS VI. The lysosomal lumen is indeed where ARSB functions to degrade glycosaminoglycans.
    action: ACCEPT
    reason: This is an accurate and specific cellular component annotation. ARSB is a soluble lysosomal
      enzyme that functions in the lysosomal lumen, where it encounters its substrates during glycosaminoglycan
      degradation. This is more specific than just &#34;lysosome&#34; and should be retained.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: The 47-kDa ASB form was located in dense lysosomes.
    - reference_id: Reactome:R-HSA-2282889
      supporting_text: Defective ARSB does not hydrolyse C4S/C6S chains [implies ARSB functions in lysosomal
        lumen]
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9036065
  review:
    summary: This is another TAS annotation for lysosomal lumen from a different Reactome pathway (defective
      ARSB not hydrolyzing dermatan sulfate). This is a duplicate of the previous annotation but from
      a different pathway.
    action: ACCEPT
    reason: While this is a duplicate GO term, it represents independent evidence from a different Reactome
      pathway, which reinforces the localization. It is acceptable to have the same term with different
      references.
    supported_by:
    - reference_id: Reactome:R-HSA-9036065
      supporting_text: Defective ARSB does not hydrolyse DS
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798751
  review:
    summary: This annotation indicates ARSB is found in the extracellular region, specifically in the
      context of azurophil granule exocytosis from neutrophils. ARSB can be secreted and found extracellularly.
    action: KEEP_AS_NON_CORE
    reason: While ARSB is primarily a lysosomal enzyme, it can be secreted and found in the extracellular
      region, particularly during neutrophil degranulation. This represents a non-core localization that
      is biologically relevant but secondary to the main lysosomal function. The annotation should be
      retained but marked as non-core.
    supported_by:
    - reference_id: Reactome:R-HSA-6798751
      supporting_text: Exocytosis of azurophil granule lumen proteins [ARSB is among the proteins released]
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: ARSB is predominantly a lysosomal enzyme. Extra-lysosomal [localizations exist]
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  review:
    summary: This is another annotation for extracellular region from Reactome, this time in the context
      of ficolin-1-rich granule exocytosis. This is a duplicate GO term with different supporting evidence.
    action: KEEP_AS_NON_CORE
    reason: This reinforces the extracellular localization through a different pathway (ficolin-rich granule
      exocytosis). As with the previous extracellular region annotation, this is a non-core localization
      but should be retained.
    supported_by:
    - reference_id: Reactome:R-HSA-6800434
      supporting_text: Exocytosis of ficolin-rich granule lumen proteins [ARSB is among the proteins released]
- term:
    id: GO:0035578
    label: azurophil granule lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798751
  review:
    summary: This annotation places ARSB in azurophil granule lumen of neutrophils. Azurophil granules
      are specialized secretory granules in neutrophils that can contain lysosomal enzymes.
    action: KEEP_AS_NON_CORE
    reason: This is a specialized, cell-type-specific localization of ARSB in neutrophils. While accurate,
      this represents a non-core localization specific to neutrophils and their degranulation processes.
      This should be retained as it is supported by Reactome but marked as non-core.
    supported_by:
    - reference_id: Reactome:R-HSA-6798751
      supporting_text: Azurophil granules are generally described as spherical. Like lysosomes, they contain
        CD63 in their membrane (Cham et al. 1994) but are regarded as specialized secretory granules rather
        than lysosomes (Cieutat et al. 1998)
- term:
    id: GO:1904813
    label: ficolin-1-rich granule lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  review:
    summary: This annotation places ARSB in ficolin-1-rich granule lumen, another type of secretory granule
      in neutrophils. This is a very specific, cell-type-restricted localization.
    action: KEEP_AS_NON_CORE
    reason: This is an extremely specific cellular compartment in neutrophils. While the annotation is
      supported by Reactome, it represents a highly specialized, non-core localization. It should be retained
      for completeness but clearly marked as non-core and cell-type-specific.
    supported_by:
    - reference_id: Reactome:R-HSA-6800434
      supporting_text: Exocytosis of ficolin-rich granule lumen proteins
- term:
    id: GO:0003943
    label: N-acetylgalactosamine-4-sulfatase activity
  evidence_type: IDA
  original_reference_id: PMID:19306108
  review:
    summary: This is another experimental (IDA) confirmation of ARSB&#39;s N-acetylgalactosamine-4-sulfatase
      activity from a different study. This study demonstrated that modulating ARSB expression affects
      chondroitin-4-sulfate content and related cellular functions.
    action: ACCEPT
    reason: This is independent experimental evidence for the core molecular function of ARSB. Having
      multiple IDA annotations from different studies strengthens the evidence for this critical activity.
      This should definitely be retained.
    supported_by:
    - reference_id: PMID:19306108
      supporting_text: Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is
        the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines
        with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S).
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: This is an ISS (Inferred from Sequence Similarity) annotation for cell surface localization,
      based on orthology to rat ARSB (P50430). This reinforces the IEA annotation for cell surface localization.
    action: ACCEPT
    reason: This annotation is based on manual curation with sequence similarity to rat ARSB and represents
      higher quality evidence than pure IEA. Combined with the literature evidence for extra-lysosomal
      membrane localization of ARSB, this annotation should be retained.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
      supporting_text: &#39;Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also
        detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells,
        and the apical membranes of colonic and prostatic epithelial cells.&#39;
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;SUBCELLULAR LOCATION: Lysosome. Cell surface.&#39;
- term:
    id: GO:0010632
    label: regulation of epithelial cell migration
  evidence_type: IMP
  original_reference_id: PMID:19306108
  review:
    summary: This experimental annotation (IMP - Inferred from Mutant Phenotype) demonstrates that ARSB
      regulates epithelial cell migration. The study showed that silencing or overexpressing ARSB had
      inverse effects on colonic epithelial cell migration.
    action: ACCEPT
    reason: This is high-quality experimental evidence showing that ARSB regulates epithelial cell migration
      through its effects on chondroitin sulfate content, MMP9 expression, and RhoA activation. While
      this is more of a regulatory role than the core enzymatic function, it represents an important biological
      function of ARSB and should be retained.
    supported_by:
    - reference_id: PMID:19306108
      supporting_text: When ASB expression was silenced by siRNA in the NCM460 cells, [...] cell migration
        increased * 52%. Following overexpression of ASB, [...] cell migration decreased * 37%. These
        findings demonstrate marked effects of ASB expression on the migratory activity of colonic epithelial
        cells
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: Involved in the regulation of cell adhesion, cell migration and invasion in colonic
        epithelium
- term:
    id: GO:0010976
    label: positive regulation of neuron projection development
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: This is an ISS annotation for positive regulation of neuron projection development, based
      on rat ortholog. This duplicates the IEA annotation for the same term but with manual curation evidence.
    action: KEEP_AS_NON_CORE
    reason: This ISS annotation provides stronger evidence than the IEA annotation for the same term.
      As discussed previously, this represents a non-core, tissue-specific function of ARSB in the nervous
      system. The annotation should be retained but marked as non-core.
    supported_by:
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: In the central nervous system, is a regulator of neurite outgrowth and neuronal
        plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity).
- term:
    id: GO:0061580
    label: colon epithelial cell migration
  evidence_type: IMP
  original_reference_id: PMID:19306108
  review:
    summary: This experimental annotation (IMP) demonstrates that ARSB affects colon epithelial cell migration
      specifically. This is a more specific term than the general &#34;regulation of epithelial cell migration&#34;
      annotation.
    action: ACCEPT
    reason: This is high-quality experimental evidence for a specific tissue type (colon) and represents
      an important biological function of ARSB. While more specific than the general epithelial cell migration
      term, this level of specificity is valuable and should be retained as it reflects the actual experimental
      system used.
    supported_by:
    - reference_id: PMID:19306108
      supporting_text: In the T84 cell line, derived from lung metastasis of malignant colonic epithelial
        cells, [...] In the T84 cells, matrix metalloproteinase 9 (MMP9), activated RhoA, and cell migration,
        as well as C4S content, were significantly more than in the NCM460 cells. Silencing and overexpression
        of ASB had inverse effects on MMP9, activated RhoA, and cell migration
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  review:
    summary: This annotation indicates ARSB is found in extracellular exosomes, based on high-throughput
      detection assay (HDA) from a proteomic study of exosomes in urine.
    action: KEEP_AS_NON_CORE
    reason: This annotation is based on proteomic detection of ARSB in exosomes. While this is a legitimate
      localization, it represents a non-core aspect of ARSB biology. Many proteins can be found in exosomes,
      and this may reflect secretion or release mechanisms rather than a primary functional localization.
      The annotation should be retained as it is experimentally supported, but marked as non-core.
    supported_by:
    - reference_id: PMID:23533145
      supporting_text: In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions
        in urine [ARSB was detected in exosomes]
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1614362
  review:
    summary: This annotation places ARSB in the ER lumen, based on Reactome pathway for SUMF1-mediated
      oxidation of cysteine to formylglycine. This post-translational modification occurs in the ER during
      ARSB biosynthesis.
    action: KEEP_AS_NON_CORE
    reason: This annotation reflects a transient localization during ARSB biosynthesis and maturation,
      not the functional localization. The formylglycine modification by SUMF1 occurs in the ER, after
      which ARSB is trafficked to lysosomes. This should be retained as it reflects an important aspect
      of ARSB biology (the post-translational modification required for activity), but marked as non-core
      since it is a biosynthetic intermediate.
    supported_by:
    - reference_id: Reactome:R-HSA-1614362
      supporting_text: SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;PTM: The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of
        a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical
        for catalytic activity.&#39;
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1606789
  review:
    summary: This is another TAS annotation for lysosomal lumen from Reactome pathway &#34;ARSB hydrolyses
      DS&#34;. This is a third annotation for the same GO term from a different Reactome pathway.
    action: ACCEPT
    reason: This reinforces the lysosomal lumen localization through another Reactome pathway focused
      on dermatan sulfate degradation. While duplicate, multiple annotations from different pathways strengthen
      the evidence.
    supported_by:
    - reference_id: Reactome:R-HSA-1606789
      supporting_text: Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate
        units
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1793207
  review:
    summary: This is a fourth TAS annotation for lysosomal lumen from Reactome pathway &#34;ARSB hydrolyses
      C4S/C6S chains&#34;. This is yet another duplicate from a different pathway.
    action: ACCEPT
    reason: This reinforces the lysosomal lumen localization through the chondroitin sulfate degradation
      pathway. Multiple pathway annotations strengthen the evidence for this core localization.
    supported_by:
    - reference_id: Reactome:R-HSA-1793207
      supporting_text: Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine
        4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate
- term:
    id: GO:0004065
    label: arylsulfatase activity
  evidence_type: TAS
  original_reference_id: PMID:2303452
  review:
    summary: This is a TAS (Traceable Author Statement) annotation for arylsulfatase activity from the
      seminal 1990 paper that cloned and characterized human ARSB. This provides experimental literature
      support for the arylsulfatase classification.
    action: ACCEPT
    reason: This is a foundational reference for ARSB characterization and provides strong experimental
      support for the arylsulfatase activity annotation. This should definitely be retained as it represents
      the original biochemical characterization of the enzyme.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human
        arylsulfatase B. [...] Overexpression of ASB in transfected baby hamster kidney (BHK) cells resulted
        in up to 68-fold higher ASB activity
- term:
    id: GO:0005764
    label: lysosome
  evidence_type: TAS
  original_reference_id: PMID:2303452
  review:
    summary: This is a TAS annotation for lysosome localization from the same foundational 1990 paper.
      This provides experimental literature support for the lysosomal localization.
    action: ACCEPT
    reason: This is strong experimental evidence from the original characterization of ARSB showing its
      lysosomal localization and mannose-6-phosphate receptor-mediated trafficking. This is core evidence
      that should definitely be retained.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes
        was accomplished in a mannose 6-phosphate receptor-dependent manner.
- term:
    id: GO:0007040
    label: lysosome organization
  evidence_type: TAS
  original_reference_id: PMID:1718978
  review:
    summary: This annotation suggests ARSB is involved in lysosome organization. The reference is to a
      1991 paper about MPS VI mutations, which describes the disease phenotype but does not directly demonstrate
      that ARSB organizes lysosomes.
    action: REMOVE
    reason: This appears to be a misannotation. While ARSB deficiency leads to lysosomal storage disease
      (MPS VI), this does not mean ARSB&#39;s primary function is to organize lysosomes. ARSB is a lysosomal
      enzyme that degrades glycosaminoglycans; its absence causes substrate accumulation and lysosomal
      dysfunction, but this is a consequence of enzyme deficiency, not evidence that ARSB actively organizes
      lysosomes. This annotation should be removed.
    supported_by:
    - reference_id: PMID:1718978
      supporting_text: The Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI) is a lysosomal storage
        disease with autosomal recessive inheritance caused by deficiency of the enzyme arylsulfatase
        B. [This describes disease, not lysosome organization activity]
- term:
    id: GO:0007041
    label: lysosomal transport
  evidence_type: TAS
  original_reference_id: PMID:2303452
  review:
    summary: This annotation suggests ARSB is involved in lysosomal transport. The reference describes
      ARSB being transported TO lysosomes via the mannose-6-phosphate receptor pathway, not that ARSB
      performs transport functions.
    action: REMOVE
    reason: This is a misannotation. The reference describes ARSB as a cargo being transported to lysosomes,
      not as performing transport functions. ARSB is a lysosomal enzyme that degrades substrates; it does
      not transport materials. This annotation confuses the trafficking of ARSB to lysosomes with ARSB
      having a transport function. This should be removed.
    supported_by:
    - reference_id: PMID:2303452
      supporting_text: Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent
        manner. [This describes transport OF ARSB, not transport BY ARSB]
- term:
    id: GO:0030209
    label: dermatan sulfate proteoglycan catabolic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1606789
  review:
    summary: ARSB is directly involved in dermatan sulfate degradation by removing 4-sulfate groups from
      N-acetylgalactosamine-4-sulfate residues. This is one of the primary catabolic pathways in which
      ARSB participates, as documented in Reactome and the cyberian deep research.
    action: NEW
    reason: This biological process annotation is missing from the existing GOA file but is a core function
      of ARSB. Dermatan sulfate is one of two primary substrates for ARSB, and its degradation is blocked
      in MPS VI patients. This annotation is well-supported by Reactome pathway documentation and literature.
    supported_by:
    - reference_id: Reactome:R-HSA-1606789
      supporting_text: Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units
        within dermatan sulfate (DS; Gorham &amp; Cantz 1978)
    - reference_id: file:human/ARSB/ARSB-deep-research-cyberian.md
      supporting_text: &#39;ARSB acts specifically on two major sulfated glycosaminoglycans: Dermatan sulfate
        (DS): A heteropolysaccharide composed of repeating disaccharide units containing iduronic acid
        and N-acetylgalactosamine-4-sulfate&#39;
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: Hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units
        of chondroitin sulfate and dermatan sulfate.
- term:
    id: GO:0006027
    label: glycosaminoglycan catabolic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1606789
  review:
    summary: ARSB participates in the broader glycosaminoglycan catabolic process through its specific
      role in degrading dermatan sulfate and chondroitin-4-sulfate. This is the parent process that
      encompasses the more specific DS and C4S catabolic activities.
    action: NEW
    reason: This biological process annotation represents the broader catabolic category encompassing
      ARSB function. While more general than the specific dermatan sulfate or chondroitin sulfate proteoglycan
      catabolic processes, it appropriately captures ARSB&#39;s role in GAG catabolism. The annotation is
      supported by Reactome pathway documentation and literature.
    supported_by:
    - reference_id: Reactome:R-HSA-1606789
      supporting_text: Defects in ARSB are the cause of mucopolysaccharidosis type VI (MPSVI) (MIM:253200,
        also called Maroteaux-Lamy syndrome
    - reference_id: file:human/ARSB/ARSB-deep-research-cyberian.md
      supporting_text: &#39;ARSB functions within the lysosomal catabolism pathway for sulfated glycosaminoglycans.
        The sequential degradation of dermatan sulfate and chondroitin sulfate requires multiple enzymes
        acting in a specific order.&#39;
    - reference_id: file:human/ARSB/ARSB-uniprot.txt
      supporting_text: &#39;DISEASE: Mucopolysaccharidosis 6 (MPS6) [MIM:253200]: A form of mucopolysaccharidosis,
        a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans&#39;
references:
- id: GO_REF:0000003
  title: Gene Ontology annotation based on Enzyme Commission mapping
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator
    judgment of sequence similarity.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping,
    accompanied by conservative changes to GO terms applied by UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl
    Compara.
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:1718978
  title: Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused
    by substitution of valine for glycine at position 137 of arylsulfatase B.
  findings:
  - statement: The G137V mutation in ARSB severely reduces stability of the precursor protein
    supporting_text: The G137V mutation did not affect the synthesis but severely reduced the stability
      of the arylsulfatase B precursor.
  - statement: Most of the mutant precursor is degraded before reaching lysosomes
    supporting_text: the majority of the mutant precursor was degraded presumably in a compartment proximal
      to the trans Golgi network and only a small amount escaped to the lysosomes
  - statement: This mutation causes an intermediate form of MPS VI
    supporting_text: accounting for the low residual enzyme activity in fibroblasts of a patient with
      the juvenile form of the disease.
- id: PMID:18285341
  title: Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on
    chondroitin sulfates.
  findings:
  - statement: ARSB (N-acetylgalactosamine-4-sulfatase) hydrolyzes sulfate groups from chondroitin sulfate
    supporting_text: The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB))
      and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS.
  - statement: Silencing ARSB increases chondroitin-4-sulfate, total chondroitin sulfate, and total sulfated
      GAG content
    supporting_text: Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly.
  - statement: Overexpressing ARSB decreases chondroitin-4-sulfate and total chondroitin sulfate
    supporting_text: Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly.
  - statement: ARSB expression affects proteoglycan core protein expression (syndecan-1, decorin)
    supporting_text: mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1 and
      decorin, was significantly up-regulated following overexpression of ASB
- id: PMID:19306108
  title: Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and
    RhoA activation.
  findings:
  - statement: ARSB removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate in chondroitin-4-sulfate
    supporting_text: Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the
      enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate
      to form the disaccharide unit of chondroitin-4-sulfate (C4S).
  - statement: ARSB activity is significantly lower in malignant T84 colonic cells compared to normal
      colonocytes
    supporting_text: In the T84 cell line, derived from lung metastasis of malignant colonic epithelial
      cells, the activity of ASB, as well as steroid sulfatase, arylsulfatase A, and galactose-6-sulfatase,
      were significantly less than in normal, primary colonic epithelial cells
  - statement: Silencing ARSB increases MMP9 secretion, activated RhoA, and cell migration
    supporting_text: When ASB expression was silenced by siRNA in the NCM460 cells, MMP9 secretion increased
      to over 3 times the basal level, activated RhoA increased * 85%, and cell migration increased *
      52%.
  - statement: Overexpressing ARSB decreases MMP9, activated RhoA, and cell migration
    supporting_text: Following overexpression of ASB, MMP9 declined 51%, activated RhoA declined * 51%,
      and cell migration decreased * 37%.
  - statement: ARSB regulates invasive phenotype of colonic epithelial cells through effects on chondroitin
      sulfation
    supporting_text: These findings demonstrate marked effects of ASB expression on the migratory activity
      of colonic epithelial cells, activated RhoA, and MMP9, and suggest a potential vital role of ASB,
      due to its impact on chondroitin sulfation, on determination of the invasive phenotype of colonic
      epithelial cells.
- id: PMID:2303452
  title: Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase
    B.
  findings:
  - statement: Human ARSB is a 533 amino acid protein with a 41 amino acid signal peptide
    supporting_text: The deduced amino acid sequence of 533 amino acids contains a 41-amino acid N-terminal
      signal peptide and a mature polypeptide of 492 amino acid residues.
  - statement: ARSB is synthesized as a 64-kDa precursor and processed to a 47-kDa mature form
    supporting_text: Pulse-chase labeling showed that ASB was synthesized and secreted as a 64-kDa precursor
      and processed to a 47-kDa mature form in BHK cells.
  - statement: ARSB localizes to dense lysosomes via mannose-6-phosphate receptor-dependent trafficking
    supporting_text: The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes
      was accomplished in a mannose 6-phosphate receptor-dependent manner.
  - statement: ARSB is a member of the arylsulfatase gene family showing phylogenetic conservation
    supporting_text: Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase,
      human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree
      of similarity suggesting that they arose from a common ancestral gene and are members of an arylsulfatase
      gene family.
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
  findings:
  - statement: ARSB was detected in exosomes from prostatic secretions by proteomic analysis
    supporting_text: In pooled EPS-urine exosome samples, ~900 proteins were detected [including ARSB]
- id: Reactome:R-HSA-1606789
  title: ARSB hydrolyses DS
  findings:
  - statement: ARSB hydrolyzes sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate
    supporting_text: Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units
      within dermatan sulfate (DS; Gorham &amp; Cantz 1978)
  - statement: Conversion of cysteine to 3-oxoalanine (formylglycine) is critical for catalytic activity
    supporting_text: The conversion to 3-oxoalanine (formylglycine, FGly) of a cysteine residue in eukaryotes,
      is critical for catalytic activity
  - statement: Defects in ARSB cause mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
    supporting_text: Defects in ARSB are the cause of mucopolysaccharidosis type VI (MPSVI) (MIM:253200,
      also called Maroteaux-Lamy syndrome (Wicker et al. 1991)
- id: Reactome:R-HSA-1614362
  title: SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases
  findings:
  - statement: SUMF1 performs post-translational modification of ARSB required for activity
    supporting_text: SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases
  - statement: This modification occurs during ARSB biosynthesis
    supporting_text: SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases
      [during biosynthesis]
- id: Reactome:R-HSA-1793207
  title: ARSB hydrolyses C4S/C6S chains
  findings:
  - statement: ARSB with calcium cofactor hydrolyzes sulfate from N-acetylgalactosamine 4-sulfate or 6-sulfate
      units in chondroitin sulfate
    supporting_text: Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine
      4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate
  - statement: Formylglycine modification is critical for catalytic activity
    supporting_text: The conversion to 3-oxoalanine (formylglycine, FGly) of a cysteine residue in eukaryotes,
      is critical for catalytic activity, based on similarity to the prototypical arylsulfatase ARSA
- id: Reactome:R-HSA-2282889
  title: Defective ARSB does not hydrolyse C4S/C6S chains
  findings:
  - statement: Loss of ARSB function prevents degradation of chondroitin sulfate chains
    supporting_text: Defective ARSB does not hydrolyse C4S/C6S chains
  - statement: This leads to MPS VI pathology
    supporting_text: Defective ARSB does not hydrolyse C4S/C6S chains [leading to MPS VI]
- id: Reactome:R-HSA-6798751
  title: Exocytosis of azurophil granule lumen proteins
  findings:
  - statement: ARSB is present in azurophil granules of neutrophils
    supporting_text: Exocytosis of azurophil granule lumen proteins
  - statement: These granules can undergo exocytosis, releasing ARSB extracellularly
    supporting_text: Exocytosis of azurophil granule lumen proteins
- id: Reactome:R-HSA-6800434
  title: Exocytosis of ficolin-rich granule lumen proteins
  findings:
  - statement: ARSB is present in ficolin-1-rich granules
    supporting_text: Exocytosis of ficolin-rich granule lumen proteins [ARSB is present]
  - statement: These specialized neutrophil granules can release ARSB through exocytosis
    supporting_text: Exocytosis of ficolin-rich granule lumen proteins
- id: Reactome:R-HSA-9036065
  title: Defective ARSB does not hydrolyse DS
  findings:
  - statement: Loss of ARSB function prevents degradation of dermatan sulfate
    supporting_text: Defective ARSB does not hydrolyse DS
  - statement: This contributes to MPS VI pathology
    supporting_text: Defective ARSB does not hydrolyse DS [contributing to MPS VI pathology]
- id: file:human/ARSB/ARSB-uniprot.txt
  title: UniProt entry for ARSB (P15848)
  findings:
  - statement: ARSB removes sulfate groups from chondroitin-4-sulfate and regulates its degradation
    supporting_text: Removes sulfate groups from chondroitin-4-sulfate (C4S) and regulates its degradation
  - statement: Involved in regulation of cell adhesion, cell migration, and invasion in colonic epithelium
    supporting_text: Involved in the regulation of cell adhesion, cell migration and invasion in colonic
      epithelium
  - statement: Regulates neurite outgrowth and neuronal plasticity in CNS through control of sulfate GAGs
      and neurocan
    supporting_text: In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity,
      acting through the control of sulfate glycosaminoglycans and neurocan levels
  - statement: Requires calcium cofactor (binds 1 Ca2+ per subunit)
    supporting_text: &#39;COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit.&#39;
  - statement: Conversion of Cys-91 to 3-oxoalanine (formylglycine) is critical for catalytic activity
    supporting_text: The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine
      or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic
      activity.
  - statement: Deficiency causes mucopolysaccharidosis type VI (MPS VI)
    supporting_text: &#39;DISEASE: Mucopolysaccharidosis 6 (MPS6) [MIM:253200]: A form of mucopolysaccharidosis,
      a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans&#39;
- id: file:human/ARSB/ARSB-deep-research-perplexity-lite.md
  title: Deep research on ARSB gene
  findings:
  - statement: ARSB is predominantly a lysosomal enzyme with extra-lysosomal localization at cell membranes
      in some cell types
    supporting_text: &#39;Primary: ARSB is predominantly a lysosomal enzyme. Extra-lysosomal: Immunohistochemistry
      and immunofluorescence studies have also detected ARSB at the cell membrane&#39;
  - statement: ARSB regulates extracellular matrix remodeling, cell migration, and signaling pathways
    supporting_text: &#39;Extracellular matrix remodeling: ARSB influences the composition and turnover of
      the extracellular matrix, affecting cell adhesion, migration, and invasion&#39;
  - statement: ARSB has tumor suppressor activity; reduced expression linked to cancer progression
    supporting_text: &#39;Cancer: Reduced ARSB expression is linked to altered proteoglycan expression and
      tumor progression in prostate and colonic epithelial cells. Acts as a tumor suppressor&#39;
  - statement: ARSB regulates neuronal development through control of sulfated GAGs and neurocan
    supporting_text: &#39;Neuronal development: In the central nervous system, ARSB regulates neurite outgrowth
      and neuronal plasticity by controlling sulfate GAG and neurocan levels&#39;
  - statement: Enzyme replacement therapy with recombinant ARSB is standard treatment for MPS VI
    supporting_text: Enzyme replacement therapy (ERT) with recombinant ARSB is the standard treatment
      for MPS VI, aiming to reduce GAG accumulation and ameliorate symptoms
- id: file:human/ARSB/ARSB-deep-research-cyberian.md
  title: Deep research on ARSB gene (cyberian)
  findings:
  - statement: ARSB catalyzes removal of 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues
      at the non-reducing end of GAG chains
    supporting_text: &#39;Arylsulfatase B (ARSB) is a sulfohydrolase that catalyzes the removal of 4-sulfate
      groups from N-acetylgalactosamine-4-sulfate residues located at the non-reducing end of glycosaminoglycan
      (GAG) chains. The systematic name of the enzyme is N-acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase
      (Bond et al., 1997; Valayannopoulos et al., 2010).&#39;
  - statement: ARSB also demonstrates activity against N-acetylglucosamine-4-sulfate as a substrate
    supporting_text: &#39;Notably, ARSB also demonstrates activity against N-acetylglucosamine-4-sulfate as
      a substrate (Bond et al., 1997). This activity is consistent with the enzyme&#39;&#39;s ability to act on
      related 4-sulfated hexosamine residues, though its primary physiological substrates remain the GAG
      chains of DS and C4S.&#39;
  - statement: Formylglycine (FGly91) is found in a sulfate-modified form at the active site, and calcium
      ion is essential for catalysis
    supporting_text: &#39;The crystal structure of human ARSB (PDB: 1FSU), solved at 2.5 A resolution, revealed
      that: Formylglycine (FGly91) is found in a sulfate-modified form (oxo-alanine sulfate ester) in
      the active site; A divalent calcium ion (Ca2+) is coordinated at the active site and is essential
      for catalysis; The calcium ion binds directly to the sulfate group of the modified cysteine residue
      (Bond et al., 1997)&#39;
  - statement: Sulfate hydrolysis proceeds through transesterification-elimination (TE) mechanism
    supporting_text: &#39;The sulfate hydrolysis mechanism proceeds through either an addition-hydrolysis
      (AH) or transesterification-elimination (TE) pathway, with current evidence favoring the TE mechanism.
      In this mechanism: The aldehyde of formylglycine becomes hydrated to a gem-diol; One hydroxyl of
      the gem-diol attacks the substrate sulfur, forming a covalent enzyme-sulfate intermediate; Elimination
      releases the product and regenerates the aldehyde (Hanson et al., 2004)&#39;
  - statement: ARSB is targeted to lysosomes via the mannose-6-phosphate (M6P) receptor pathway
    supporting_text: &#39;The mature enzyme of 533 amino acids is generated after cleavage of the signal
      peptide and is targeted to lysosomes via the mannose-6-phosphate (M6P) receptor pathway (Braulke
      &amp; Bonifacino, 2009).&#39;
  - statement: ARSB participates in extracellular GAG remodeling at the plasma membrane and in the
      extracellular matrix
    supporting_text: &#39;While primarily a lysosomal enzyme, ARSB also exhibits extra-lysosomal localization.
      Studies have demonstrated ARSB presence at the plasma membrane and in the extracellular matrix,
      where it participates in local GAG remodeling (Bhattacharyya et al., 2009).&#39;
  - statement: ARSB modulates galectin-3 binding and SHP-2 phosphatase activity through control of chondroitin
      sulfation
    supporting_text: &#39;Beyond its housekeeping role in GAG catabolism, ARSB has emerged as a regulator
      of cellular signaling and gene expression. By controlling the sulfation status of cell-surface and
      extracellular GAGs, ARSB modulates: Galectin-3 binding: The degree of chondroitin 4-sulfation affects
      galectin-3 sequestration and release, influencing downstream signaling; SHP-2 phosphatase activity:
      ARSB activity impacts SHP-2 localization and function (Bhattacharyya et al., 2022)&#39;
  - statement: ARSB functions as a tumor suppressor, transcriptional mediator, and regulator of cellular
      signaling
    supporting_text: &#39;These broader roles suggest ARSB functions as a tumor suppressor, transcriptional
      mediator, and regulator of cellular signaling beyond its classical lysosomal function.&#39;
  - statement: The ARSB protein structure contains an active site domain resembling alkaline phosphatase
    supporting_text: &#39;Despite lacking detectable sequence similarity, the ARSB active site domain closely
      resembles that of alkaline phosphatase. The calcium in ARSB superimposes on one of the zinc ions
      in alkaline phosphatase, and the oxo-alanine sulfate ester superimposes on the phosphate ion in
      alkaline phosphatase (Bond et al., 1997)&#39;
  - statement: Over 220 unique ARSB variants have been identified causing MPS VI
    supporting_text: &#39;Genetic heterogeneity: Over 220 unique ARSB variants have been identified, including
      Missense variants: 59.5%, Small deletions: 13.5%, Nonsense mutations: 12.0%, Splice site variants:
      5.0%&#39;
core_functions:
- description: Hydrolyzing 4-sulfate groups from N-acetylgalactosamine residues within dermatan sulfate
    and chondroitin-4-sulfate glycosaminoglycan chains in the lysosomal lumen
  molecular_function:
    id: GO:0003943
    label: N-acetylgalactosamine-4-sulfatase activity
  directly_involved_in:
  - id: GO:0030209
    label: dermatan sulfate proteoglycan catabolic process
  - id: GO:0030207
    label: chondroitin sulfate proteoglycan catabolic process
  - id: GO:0006027
    label: glycosaminoglycan catabolic process
  locations:
  - id: GO:0043202
    label: lysosomal lumen
  substrates:
  - id: CHEBI:18376
    label: dermatan sulfate
  - id: CHEBI:18250
    label: chondroitin 4&#39;-sulfate
  supported_by:
  - reference_id: PMID:19306108
    supporting_text: Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the
      enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate
      to form the disaccharide unit of chondroitin-4-sulfate (C4S).
  - reference_id: PMID:18285341
    supporting_text: The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB))
      and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS.
  - reference_id: Reactome:R-HSA-1606789
    supporting_text: Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units
      within dermatan sulfate (DS)
  - reference_id: Reactome:R-HSA-1793207
    supporting_text: Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine
      4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate
  - reference_id: PMID:2303452
    supporting_text: The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes
      was accomplished in a mannose 6-phosphate receptor-dependent manner.
  - reference_id: file:human/ARSB/ARSB-uniprot.txt
    supporting_text: &#39;COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit.&#39;
  - reference_id: file:human/ARSB/ARSB-deep-research-cyberian.md
    supporting_text: &#39;The crystal structure of human ARSB (PDB: 1FSU), solved at 2.5 A resolution, revealed
      that: Formylglycine (FGly91) is found in a sulfate-modified form (oxo-alanine sulfate ester) in
      the active site; A divalent calcium ion (Ca2+) is coordinated at the active site and is essential
      for catalysis&#39;
  - reference_id: file:human/ARSB/ARSB-deep-research-cyberian.md
    supporting_text: &#39;The sulfate hydrolysis mechanism proceeds through either an addition-hydrolysis
      (AH) or transesterification-elimination (TE) pathway, with current evidence favoring the TE mechanism.&#39;
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>